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Influenza A virus is a very important pathogen as it can cause both health 
and economic burden around the world. It causes annual epidemics and 
occasional pandemics. IAV is a negative sensed enveloped RNA virus. 
Influenza is pleomorphic in nature, meaning it can form different 
morphologies, mainly spherical and filamentous. Filamentous viruses are 
well documented, but how and why they form is still not known. However, it 
is known that filamentous viruses enter host cells by macropinocytosis, 
while spherical viruses mostly enter by clathrin mediated endocytosis 
(Rossman et al., 2012).  
Both host and viral factors can have a role in the formation of the 
morphology of the virions. It is also believed that host factors can also have 
an effect on infectivity of the virus. In this study, the focus was on how viral 
morphology can affect innate immune response at early stages of infection. 
It was shown that filamentous virions can reduce the activation of the NF-
kB thus reducing its signalling. As NF-kB is one of the first responders of 
the host’s immune system, this means filamentous virions can successfully 
reduce the effects of the innate immune system during early infection. Here, 
we tried to find the steps that the filaments follow to bring about this 
reduction in activity. 
Influenza virus uses clathrin mediated endocytosis and macropinocytosis 
to enter host cells. When both the pathways are blocked it was thought that 
infection should decrease. However, it was noticed that blocking clathrin 




mediated endocytosis and micropinocytosis increases infectivity of 
spherical viruses. We are proposing that IAV can enter cells by a third 
pathway. 
It had been proposed that some non-infectious filamentous virions exist. 
The main purpose of these viruses is suggested to be to prime host cells, 
for increasing the cellular entry rate of the infective virions which follow it. It 
has been shown in this study that this concept is not true and priming of 
host cells beforehand does not help with consecutive infection.  
Understanding the morphology of filaments is a complex process. This 
study looked at filamentous virion’s infectivity through cellular entry and the 





























1.1 Influenza Virus: An Important Pathogen 
Influenza Virus is a cause of annual epidemics and occasional pandemics 
all over the world. It can cause high rate of morbidity and mortality and has 
large socio-economic cost, causing financial and economic burdens to 
society. Influenza viruses play a vital role in human health.  
Influenza Virus can be one of four types: A, B, C and D. Of the four, A, B 
and C infect humans, and A predominantly causes most of the infections 
by influenza viruses. Influenza A Virus (IAV) was the cause of the most 
severe viral outbreak known in 1918, where more than 50 million people 
were killed in one year, during the First World War, which is more than the 
number of people who were killed due to the war itself (Johnson and 
Mueller, 2002). This is now known as ‘Spanish’ Flu. IAV has continued to 
spread pandemics throughout the world, including the ‘Asian’ Flu in1957 
and ‘Hong Kong’ Flu in 1968, which are each believed to have caused about 
1 million deaths (Kilbourne, 2006). A more recent outbreak was the ‘Swine’ 
Flu pandemic in 2009, where it affected 60 million people, and caused 
12000 deaths in the USA alone (Badham and Rossman, 2016). 
In the USA, it has been estimated that the direct costs related to 
hospitalisation of IAV-infected children younger than 5 years old is $809 
million annually, on average. In addition, children (under 5) treated at 
outpatient visits add another $389 million annually to the cost (Molinari et 
al., 2007, Wang et al., 2013). However, these figures do not include the 
indirect costs (e.g. work leave, transport costs etc.) which can increase the 




costs even higher. According to WHO/IVB/16.04, the total economic burden 
needs to include direct medical costs, direct non-medical costs and indirect 
costs, highlighting the significant economic costs of annual IAV outbreaks. 
It had been estimated that from 2001/2002 to 2008/2009 the healthcare 
costs in the US ranged from $2.0-5.8 billion (Yan et al. 2017). 
 
1.2 Disease and Epidemiology 
Influenza infection is very contagious and causes respiratory tract infections 
in humans and other animals (birds, pigs, horses, seals etc.). The 
symptoms for mild IAV infection are fever, headache, sore throat, 
congestion and muscle aches. However, in severe cases the symptoms 
can progress to severe cough, wheezing, breathing difficulties and 
respiratory failure (Coates et al. 2016). Although anyone can be infected by 
influenza viruses, it is believed that children under the age of 5 and people 
who are 65 and over are more susceptible to severe infection (CDC, 2018).  
It is thought that most of the infection is spread through the air by respiratory 
droplets when an infected individual cough, sneezes or talks. In addition, 
IAV can also spread by surface contact when someone touches a surface 
with IAV on it, and then touches their mouth, nose or eyes. During the first 
3-4 days of infection, the individual is most contagious, and can spread the 
virus before they themselves start showing symptoms. It usually takes 
about 2 days for the onset of infection, but can go up to 4 days (CDC, 2018). 




There are vaccines (depending on age groups and seasonal outbreaks) 
and antiviral medications (Tamiflu) available to treat influenza infections. 
IAV is a very successful virus and has survived due to its ability to adapt 
and evade the human immune system. One of the main ways it can survive 
is by antigenic variations in the hemagglutinin (HA) and neuraminidase (NA) 
glycoproteins. IAV can continuously change its antigenic properties, 
through the introduction of point mutations in the HA and NA genes during 
error-prone replication, which can amplify in favourable conditions, thus 
giving rise to annual epidemics. This process is known as ‘antigenic drift’ 
(Cox and Subarao, 2000). Sometimes, more than one variant of influenza 
virus can co-infect a cell, leading to a complete reassortment of the viral 
genomic segments, and giving rise to a new viral subtype. This is known as 
‘antigenic shift’, and cause pandemic strains to form. As this can result in a 
completely new strain for which individuals may have no existing immunity, 
they can often spread rapidly through the human population (Strauss and 
Strauss, 2008). 
Infectivity of IAV varies between different types of cells, and HA determines 
the cells capable of being infected. During seasonal IAV infection, HA binds 
to α2-6 sialylated glycans which are found in the upper respiratory tracts of 
many mammals (Shinya et al., 2006). However, in more pathogenic strains 
of IAV, HA binds to α2-3 sialyated glycans in the lower respiratory tract, 
resulting in infection of type 2 pneumocytes of lungs and alveolar 
macrophages (Fukuyama and Kawaoka, 2011). Furthermore, some strains 




of IAV can also infect gastrointestinal cells, though the function of this cell 
type in IAV infection is not known (Horimoto et al., 1997). 
 
1.3 Structure of Influenza Virus 
IAV belongs to the Orthomyxoviridae family. This family comprises 
pleiomorphic (filamentous and spherical) enveloped viruses that have a 
segmented single-stranded negative-sense RNA genome (Palese, 2007). 
The virus types (e.g. IAV) can be classified by the antigenic differences in 
the main virion proteins, the nucleoproteins (NP) and Matrix Protein 1 (M1). 
IAV is further classified into 16 HA and 9 NA subtypes, again depending on 
their antigenic and genetic properties (Noda, 2012). These subtypes lead 
to the naming of different Influenza virus strains, e.g. A/Udorn/1972 (H3N2) 
is an Influenza A virus, isolated from the Udorn valley in Russia in 1972 and 
is antigenically classified as HA type 3 and NA type 2 (Noda, 2012). 
The IAV genome is formed by eight RNA segments and eleven genes. 
These express several different proteins, which can be categorised as 
structural and non-structural proteins. The structural proteins include HA, 
NA, NP and matrix proteins one and two (M1 and M2), and in addition they 
have functional roles as well. On the other hand, polymerase subunits 
[polymerase basic 1 (PB1), polymerase basic 2 (PB2) and polymerase acid 
(PA)] and non-structural proteins (NS1), are the non-structural proteins, and 
have functional roles which help in virus replication (Badham and Rossman, 
2016). Before transporting and assembling, the NP proteins binds to the 




polymerase subunits to package the viral genome. They also interact with 
different cellular proteins to export the replicated viral genome to the 
nucleus (Badham and Rossman, 2016). 
HA is the most abundant envelope protein. IAV viruses contain at least 500 
copies of HA per virion, which function as the receptor for binding and 
membrane fusion activity. In comparison, NA has fewer copies in the virion 
and is mainly involved in enzymatic activity, cleaving sialic acid bonds and 
releasing newly formed virus particles (Badham and Rossman, 2016). HA 
and NA can be seen as the glycoprotein spikes on the surface of the virion 
in a ratio of 1:4 approximately (Noda, 2012). The least abundant viral 
protein is the M2 protein, comprising only of 20-60 copies in each virion. M2 
plays a major role in viral entry, assembly and budding (Wilschut et al., 
2006, Rossman, 2011). The most abundant structural protein of IAV is M1, 
and this lies on the inside of the viral envelope. M1 can interact with the 
ribonucleoprotein complex (RNP) (Watnabe et al., 1996) and with the 
surface glycoproteins HA and NA (Enami and Enami, 1996) to play a major 
role in genome nuclear export, assembly and budding. RNPs are comprised 
of the viral RNA (vRNA) segments, NP and the three polymerase proteins, 
PB1, PB2 and PA (Palese and Shaw, 2007). An additional protein variant 
of PB1, PB1-F2 can be seen in some strains, and is thought to have a pro-
apoptotic activity (Wilschut et al., 2006). The non-structural protein 1 (NS1) 
plays an important role in antagonizing the host antiviral response and 
aiding replication. NS1 can restrict host immunity at different levels, 
including binding to the 30kDa subunit of polyadenylation specificity factor 




(CPSF30) and the poly(A) binding protein II (PABPII) which can inhibit 
cellular mRNA processing. This in turn can block the host antiviral response 
(Wing-Yee-Mol et al., 2012). Previously believed to be a non-structural 
protein, the nuclear export protein (NEP/NS2) helps in the nuclear export 
of viral RNPs. Later it was found to be incorporated into the virus particle in 
small quantities (Richardson and Akkina, 1991). The structure of IAV is 
shown in Figure 1.1. 
 
Figure 1.1 Structure of Influenza Virus showing the proteins in the virus. 
The virus consists of an RNP complex with 8 negative stranded RNA 
segments, the NP protein and RNA polymerase proteins. There is a layer 
of M1 protein, just beneath the lipid bilayer, and the membrane contains the 
M2 ion channel. The HA and NA glycoproteins are embedded in the 
membrane and seen as the outer layer of the virion. Figure modified from 
Lambs and Krug, 2004. 




1.4 Budding of IAV 
The infection of the virus can be spread from cell to cell and from one host 
to another. Infected cells release infectious particles from specific cellular 
sites, after the viral components are organised and concentrated through a 
series of budding events (Schmitt and Lamb, 2005). The process of 
assembly and budding is very complex and is thought to occur in the lipid 
raft domains on the surface of the infected cell, with the help of HA, NA, M1 
and M2 (Rossman and Lamb, 2011). Figure 1.2 summarises the current 
model of influenza virus budding. 
Influenza budding is a complex process, requiring all the viral proteins at 
different stages. It is known however that all influenza virions form at lipid 
raft domains in the plasma membrane of the infected cell (Chen et al. 2007, 
Leser and Lamb, 2005, Takeda et al., 2003). The lipid rafts concentrate 
proteins in specific regions and work as functional domains (Lingwood and 
Simons, 2010). The HA and NA proteins are exclusively found in these 
domains (Chen et al., 2007) and HA is capable of forming rafts within these 
domains, resulting in a viral ‘budozone’ (Schmitt and Lamb, 2005). The HA 
and NA proteins are thought to initiate the budding process (Wang et al., 
2010). Budozone clustering of the HA and NA proteins is thought to alter 
the membrane curvature which sets off the budding process. The 
cytoplasmic tails of these proteins then act as anchors for M1 to bind, and 
this may lead to M1 polymerization. M1 is thought to make further changes 
to membrane curvature, helping the budding to continue. NP and the RNPs 
bind to M1 at this point, which also recruits the M2 protein at this site, further 




altering membrane curvature and resulting in membrane scission, so that 
the virions can be released (Rossman and Lamb, 2011). NA then cleaves 














Figure 1.2 Model of Influenza Virus Budding (Rossman and Lamb, 2011). 
In figure A, it can be seen that HA (red) and NA (orange) cluster in the lipid 
raft domains to cause initiation of budding of influenza virus. M1 (purple) 
binds to the cytoplasmic tails of HA and NA. This acts as a docking site for 
the vRNPs (yellow) to come and attach. In Figure B, it can be seen that the 
budding virions elongate. The M1 proteins get polymerized which causes 
the vRNPs to localize, and the M2 (blue) interacts with M1 at the periphery. 
Figure C shows the occurrence of membrane scission due to the M2 
amphipathic helix which leads to the change in membrane curvature and 
the release of the budding virus. Figure D shows all the above processes- 
HA and NA come together in the lipid rafts leading to the formation of a 
filamentous virion, resulting in viral release due to the clustering of M2 at 
the neck of the virus and its membrane scission activity. 




1.5 IAV entry pathways 
Entry of spherical influenza virions has been widely studied, and has been 
determined that the virions enter cells via clathrin-mediated endocytosis. 
When the virus reaches the host cell, HA binds to the sialic acid moieties of 
host glycoproteins (Chu and Whittaker, 2004). When the HA binds to these 
glycoproteins it triggers the virion to enter the cell by clathrin-dependent 
receptor mediated endocytosis. This occurs through the Epsin-1 adapter 
protein through a dynamin dependant process (Chen and Zhuang, 2008). 
Once the virus enters the cell, it passes through the endosomal maturation 
pathway, which creates a low pH, and this triggers the HA to be activated. 
Once activated, HA mediates fusion of the virus and host endosomal 
membranes (Yoshimura and Ohnishi, 1984). The low pH also activates the 
M2 proton channel protein, so that protons can enter the virus and make it 
more acidified. This in turn releases the M1 protein from the RNP core, 
enabling the RNP to be trafficked into the nucleus, which is necessary for 
viral replication (Rossman et al., 2012). Once viral genome is replicated in 
the nucleus, it is exported through NS2 and travels through the 
Endoplasmic Reticulum (ER) to the Golgi Apparatus, and then to the cell 
membrane where they await to be incorporated in budding virions, as 
described earlier in Section 1.4. This is shown in Figure 1.3. 
However, filamentous virions are much larger in size, and it is not possible 
for them to enter host cells via clathrin mediated endocytosis. It has been 
suggested by Rossman, Lesser and Lamb (2012) that influenza viruses can 
also use macropinocytosis to enter cells. Filamentous influenza uses  














Figure 1.3 Spherical IAV enters host cells via clathrin mediated 
endocytosis. The IAV binds to host cell sialic acid moieties via the HA 
protein which induces the virus to be taken up. It passes through the 
endocytic pathway and is trafficked through the endosomes, experiencing 
a continuous drop in ph. When the pH is about 5.5 the HA goes through a 
conformational change which dismantles the virus core, and the vRNPs 
enter the cytoplasm (Sieczkarski and Whittaker, 2005). The vRNPs then 
enter the nucleus, where transcription and replication occur, and are then 
transported via the ER to the Golgi apparatus and then to the cell 








macropinocytosis as a primary entry pathway, while the spherical virions 
can also utilise it as an alternate pathway. Macropinocytosis is a type of 
endocytosis to collect solutes in bulk, and thus can take up dissolved 
molecules, viruses, bacteria, cell fragments etc. along with it (Falcone et 
al., 2006). Upon activation, membrane ruffles form on the cell surface, 
which in turn can form large endocytic vacuoles termed macropinosomes 
(Lim, 2011). This is shown in Figure 1.4. Macropinosomes depend on actin 
to be activated and need growth factors like Colony Stimulating Factor-1 
(CSF-1), Epidermal Growth Factor (EGF) or Platelet Derived Growth Factor 
(PDGF) for activation (Burry, 1990). During macropinocytosis, the entire 
filamentous virus is engulfed from the cell surface and trafficked to an 
acidified compartment. It passes through early and late endosomes, and 
goes through decreasing ph. When the pH reaches 5.5 the virus goes 
through a conformational change which us induced by the HA. This causes 
the viral envelope and the vesicle membrane to fuse (Sieczkarski and 
Whittaker, 2005). The low pH of the compartment also causes the activation 
of M2 and causes the amphipathic helix to cause changes in membrane 
curvature, fragmenting the filaments and helping membrane fusion. This 
helps the filaments to avoid the size constraint of the clathrin-coated 
vesicles, and facilitates entry into cells (Rossman et al., 2012).  
 
 





Figure 1.4 Macropinocytosis is a process of engulfing solutes in bulk. Along 
with the solute, other particles can also be taken up, including viruses. 
Ruffles form on the surface of the cell, which helps to engulf the particles 
and form the macropinosomes. These acidify, mature and eventually fuse 










Figure 1.5 Electron Microscopy images showing micropinocytosis 
occurring engulfing filamentous influenza viruses. Figure a shows the virus 
being engulfed into the cell after initiating micropinocytosis. Figure b shows 














1.6 Viral Morphology 
The influenza virus can display various morphologies and are thus known 
as pleomorphic. The morphologies can range from spherical to filamentous 
(which are most commonly seen during human infection), with intermediate 
structures looking ovoid or ellipsoidal (Noda, 2012), (Cader et al., 2011). 
Certain IAV strains exist which only forms spherical structures. However, 
the filamentous strains are always seen as a mixture of spheres and 
filaments. Despite the length of the virion, it is believed that all the 
morphologies have one IAV genome, making each virion a single infectious 
unit. Figure 1.6 shows the spherical and filamentous morphologies of 
influenza virus. 
The spherical viruses, as named, are spherical in shape, and usually have 
a diameter of 120nm. The filamentous structures are more elongated, and 
are commonly a few micrometres long, but can go up to 10um in length. 
The spheres are common in laboratory grown strains, while the filaments 
are observed more in samples from clinical isolates (Choppin and Murphy, 
1960, Chu et al., 1949, Elton et al.,2013, Itoh et al., 2009, Hayase et 
al.,1995, Kilbourne and Murphy, 1960).  
Filamentous structure is conserved across IAV strains and hosts, indicating 
that it has some advantages in the host which may be lost when grown in 
a laboratory setting. The changes in morphology has so far not shown any 
effects on transmissibility and infectivity (Choppin and Murphy, 1960). The 
ability of certain strains to form filamentous virions depend on their genetical 




features (Kilbourne and Murphy, 1960).  Irrespective of the HA and NA 
subtype of the viral strain, filamentous structure is continuously produced 
naturally, which suggests that they are important in survival of the virus in 
the nature (Siezkarski and Whittaker, 2005).  
 
Furthermore, it is noticed that continuous passaging of a filamentous strain 
in a chicken egg causes the strain to go through a morphological 
adaptation, causing only spherical virions to form. However, when a 
spherical strain is grown in guinea pigs, adaptation restores the ability to 
grow filaments (Choppin and Murphy, 1960, Kilbourne, 1959).  
Many different viral and host factors can influence the viral structure to be 
either spherical or filamentous. The virus undergoes different mutations to 
adapt to the different environments and thus the phenotype changes 
accordingly. However, despite much research it is not known what the 
function of influenza virus morphology is.  
 
 










Figure 1.6 TEM images of spherical IAV (A) and filamentous IAV (B). 
Supernatant from A/Udorn/72 infection was negative stained and imaged 
by TEM. Scale bar shows 100nm. Figure C is adapted from Choi et al 










What determines the viral morphology is a subject that has been 
investigated by different studies over the years. Most of these studies look 
at M1 and M2 as the determining the viral factors which affect viral filament 
formation. M1 protein is not only an important determinant of assembly and 
budding of both filamentous and spherical virion, but also plays a major role 
in filament formation (Elleman and Barclay, 2004). The maintenance of the 
viral morphology predominantly lies at the intersection between the M1 
protein the viral envelope and a minimal role of the RNPs. M1 is the most 
abundant protein, and it resides under the viral envelope and interacts with 
HA, NA and cytoplasmic tail of the M2 to bring about the specific viral 
morphology (Elton et al., 2013, Lakdawala, 2011) and oligomerises into a 
ribbon like structure (Badham and Rossman, 2016, Nayak et al., 2004, 
Rossman et al., 2010). It has also been noticed that M2 protein plays an 
important role in viral morphology and changes in the c-terminal 
amphipathic helix and can have a direct effect on the viral morphology 
(Badham and Rossman, 2016). 
When there are specific mutations in M1, it can lead to changes in the virus 
morphology. For example, in A/Udorn/72 strain it has been shown that 
changes in amino acids at position 41, 95 and 218 of M1 (Figure 1.6C) can 
change the filamentous phenotype. Of these three changes, alteration at 
position 41 shows the most significant changes in viral morphology. At 
position 41, the matrix protein encodes a highly conserved alanine residue 
in human and avian lineages.  If the alanine residue is mutated, it has very 
limited effect on the growth of the virus, but the morphology of the virus 




changes significantly. If the alanine is replaced by a valine at this position, 
the filamentous morphology is lost. In A/Udorn/72 strain, an A41V mutation 
causes the filamentous morphology to be entirely missing (Campbell et al., 
2014, Badham and Rossman, 2016).  
It was also shown by Chen et al, 2007, that the M1 protein is not required 
to form bacilliform (<1um) or spherical virions but is required to form 
filamentous virions. Furthermore, it was shown that in filaments the M1 
protein forms a helical structure that may be different from that seen in 
spheres. These suggest that structural changes in the M1 protein are 
important determinants of the morphology of IAV. M1 forms a scaffold like 
complex under the viral envelope that interacts with NA, HA and M2 
proteins. The M2 protein may stabilise this complex to allow the continuous 
polymerisation of M1 which helps in filament formation (Badham and 
Rossman, 2016). If there are mutation of the C terminal amphipathic helix 
of the M2 (which is predicated to interact with M1), then a filamentous virion 
can turn into a spherical one. If there is a truncation at residue 70 of the C 
terminal helix, then filaments form in an otherwise spherical virus. Also, it 
was observed that a single amino acid change (Y76A) in the M2 
cytoplasmic tail of a filamentous strain, causes the length and number of 
filaments produced to be reduced. This suggests that M2 changes 
filamentous morphology by interacting with M1, while M1 determines the 
actual structure of the virus. This means that viral morphology is a complex 
and multistep process, with different determinants involved in forming the 
structure (Badham and Rossman, 2016).  




Not only are the viral factors responsible for the morphological 
determination of IAV, but host factors can also play a role. It has been 
observed that the virus adapts in response to different host factors, which 
implies that the host organism influences morphology-specific functions. As 
described before, the filamentous virions are seen in human clinical 
isolates, but when they are continuously passaged in embryonated chicken 
eggs, they change morphology to become more spherical (Choppin and 
Murphy, 1960, Kilbourne, 1959). However, if the filamentous virions 
(especially A/Udorn/72) are passaged on Madin-Darby Canine Kidney 
(MDCK) cells, they retain their filamentous morphology (Choppin and 
Murphy, 1960, Seladi-Schulman et al., 2013, Burnet and Lind, 1957). For 
this reason, the A/Udorn/72 strain was grown in MDCK cells for most of the 
work which will be described in the later sections. 
It has been observed that in polarised MDCK cells, when Udorn is grown it 
forms highly filamentous virus that bud from the apical plasma membrane 
(Scheiffele et al, 1999, Zhang et al., 2000). This can explain why the upper 
respiratory tract is the primary site of IAV infection, as the epithelial cells 
here are highly polarised (Badham and Rossman, 2016). However, 
filamentous virions can also form in human embryonic kidney 293T cells, in 
absence of polarisation and without a defined apical membrane (Bruce et 
al., 2009), showing that filament formation is a much more complex process 
than previously thought.  
From previous research it has been shown that when the actin cytoskeleton 
of host cells was disrupted, filament formation was decreased, but there 




was no effect on spherical virion budding (Roberts and Compans, 1998). It 
was also reported that Rab11 and Rab11 family interacting protein 3 (FIP3) 
are important for filament formation (Bruce et al., 2010). Rab11 is 
necessary for IAV budding for all morphologies by trafficking the viral RNP 
to the site of budding, while Rab11-FIP3 is used in filamentous virion 
formation by regulating the localising and trafficking of unknown target 
proteins (Bruce et al., 2010, Hales et al., 2001). In a complex process, 
Rab11 interacts with PB2 of the viral RNP complex (Ying et al., 2013). 
Rab11 then traffics the RNPs to the site of virus budding through the 
microtubule network, and interacts with M1 to aid in the budding, potentially 
affecting filament formation (Martin and Helenius, 1991). 
 
 
1.7 Host Factors Affecting IAV Infection 
Although, the full extent has not been shown of what viral and host factors 
play a role in viral morphology, it is known that they both have their own 
individual roles which determines the structure of the virion. Furthermore, it 
is possible that host immune factors influence influenza infectivity and 
morphology at both innate and adaptive immunity stages (Fukuyama and 
Kawaoka, 2011). Innate immunity of the host is very important in the early 
stages of IAV infections (Cauldwell et al., 2014). For successful infection of 
IAV, the virus must overcome the host’s immune system.  
When IAV infects a host, it releases its RNA which traffics through the 
cytoplasm to the nucleus to be replicated. Toll-like receptor 7 (TLR7) and 




retinoic-acid-inducible-gene I (RIG-I) are pattern recognition receptors 
(PRR) that recognise the RNA of the virus and activate the Interferon (IFN) 
antiviral response (Koyama et al., 2007, Wu et al., 2007, Lee et al 2013). 
TLR7 and RIG-I activate the Nuclear factor kappa-light-chain-enhancer of 
activated B cells (NF-kB) pathway, resulting in the production of 
inflammatory proteins, including IFN (Kawai and Akira, 2010). Furthermore, 
during virus infection autophagy can be activated, and autophagosomes 
contain viral proteins which again can be recognised by endosomal and 
autophagosomal TLRs (Fukuyama and Kawaoka, 2011, Kawai and Akira, 











Figure 1.7 TLR7 can recognise the single stranded RNA of IAV. Activated 
TLRs then activate the NF-kB pathway. THE ssRNA of IAV can be 
presented to TLR7 during viral genome trafficking or during the process of 
autophagy (Kawai and Akira, 2010). 
 
1.7.1 NF-kB Activation During IAV Infection 
NF-kB is an important protein complex involved in regulating DNA 
transcription, cytokine production and cell survival. It can be found in almost 
all animal cells. NF-kB is a key player in the immune response to infections 
and is one of the central mediators of immune responses (Hiscott et al., 
2006). When NF-kB does not function correctly it can lead to different 




problems including cancer, autoimmune diseases and viral infections 
(Meffert et al., 2003).  
NF-kB pathway is an attractive target for viral pathogens to evade activating 
the host immune response. When a host cell is exposed to a pathogen, the 
activation of NF-kB can be almost immediate, as it does not require de novo 
protein synthesis, and is trafficked to the nucleus within minutes (Hiscott et 
al., 2001). This leads to strong transcriptional stimulations of many early 
cellular anti-viral genes and can regulate both pro- and anti-apoptosis 
signals. Viruses are very proficient in exploiting the anti-apoptotic properties 
of NF-kB and influences the host defence mechanism, to reduce the killing 
of infected of cells or effect apoptosis to increase the release of virions from 
the infected cells (Hiscott et al., 2001). Furthermore, NF-kB plays important 
roles in cell growth and proliferation, which makes it a more attractive target 
for the virus to manipulate, causing more virus growth (Hiscott et al., 2001).  
It has been suggested that IAV overexpresses HA, NP and M1 to activate 
the NF-kB pathway. 
Inactivated NF-kB stays in the cytoplasm of cell, which still have not 
received any stress signals. The location of NF-kB I determined by IkB 
proteins, a family of inhibitory proteins. The IkB proteins directly bind to NF-
kB proteins, preventing it from entering the nucleus. When the cell receives 
a stimulus, it undergoes phosphorylation and ubiquitination, which 
degrades the IkB. Without the bound IkB, the NF-kB can move to the 
nucleus and regulate gene transcription (Karin and Ben-Neriah, 2000). 
During IAV infection, when NF-kB gets activated it in turn activates the host 




immune response and the non-structural NS1 protein of IAV acts as an 
antagonist to suppress the host IFN response (Hiscott et al., 2001, Gaur et, 




Figure 1.8 Mammalian TLR signalling pathways, including the NF- κB 
signalling cascade. The NF-kB signalling pathway goes through a cascade 
of steps before it is activated and enters the nucleus to activate gene 
transcription to produce pro-inflammatory cytokines. Different TLRs are 
involved in the activation of this process (Figure modified from L. O’Neill et 
al 2013). 
 




1.7.2 Pattern Recognition Receptors and NF-kB Activation 
Toll-like receptors (TLRs) are an important group of proteins which are vital 
for the innate immune system. TLRs are single, membrane spanning, non-
catalytic receptors which are mainly found in immune cells, including 
dendritic cells and macrophages. These cells are important for recognizing 
the structural components of microbes which are conserved in nature and 
are thus crucial for the innate immune response to pathogens. When the 
microbes come in contact with the host cell, TLRs are ready to recognise 
them and activate the immune cells against them (Mahla, 2013). 
The host innate immune system mainly recognises microorganisms and 
respond to it via TLRs and other PRRs. TLRs can identify and respond to 
pathogen associated molecular patterns (PAMPs), and in turn activate 
intracellular signalling pathways (e.g. NF-kB) and lead to changes in 
immune gene expression. In viruses, TLRs can recognise structures like 
nucleic acids and enveloped glycoproteins. This TLR activation leads to a 
cascade of signalling pathways which activates Type I interferons, 
inflammatory cytokines and chemokines, which induce the anti-viral state 
and can facilitate pathogen clearance (Xagorari and Chlichlia, 2008).  
TLRs 3,7,8 and 9 are responsible for recognising viral nucleic acids- 
dsRNA, ssRNA and CpG oligodeoxynucleotides. In influenza virus 
infection, TLR 7 activates Type I interferons and NF-kB (to activate pro-
inflammatory cytokines, e.g. IL-6, TNF- α), which leads to inflammation and 
in turn reduces IAV replication and budding, while triggering the activation 




of adaptive immunity development (Koyama et al., 2007, Wu et al., 2007). 
Lee et al (2013) suggested that there is another cytosolic system of RIG-1 
like receptor proteins (RLRs) that can also detect influenza viral RNAs and 
aiding in the innate response. The influenza vRNA is a potent activator of 
TLR7, which through the MyD88 pathway can induce the production of type 
I IFN and NF-kB (Wang, et al., 2006). The cascade of the TLR pathway, 
including the activation of IKKB pathway, is shown in Figure 1.8. 
When TLR7 gets activated due to influenza infection, MyD88 recruits IL-1 
receptor kinases, including IRAK4 which is vital for the activation of NF-kB. 
K63 ubiquitin recruits TAK1 to form IKK complex, which causes 
phosphorylation of the IkB proteins. This then causes NF-kB to be 
activated, enter the nucleus and activate transcription (Kawai and Akira, 
2010).  
 
1.7.3 Autophagy and IAV 
Autophagy is a regulated mechanism by which cells degrade and recycle 
unwanted or toxic cellular components. It takes place in all nucleated cells, 
helps to maintain cellular homeostasis (Ryter et al., 2013) and is seen to 
increase during stress and viral infections (Kroemer et al., 2010, Perot et 
al., 2018). Like apoptosis, autophagy is induced when the cell receives 
signals of DNA damage, oxidative stress or cell starvation (Desai et al., 
2015). During the autophagy process, there are a series of rearrangements 
of the membrane, which causes the targeted material to be engulfed by 




double membraned autophagosomes. These in turn fuse with lysosomes 
and the content inside is degraded (Desai et al., 2015). Other than protein 
degradation, autophagy is also suggested to aid in host’s immunity. 
Autophagosomes take up the microbes and degrade them, and they 
present the microbial proteins to TLR receptors. The receptors in turn can 
activate the immune responses (Levine et al, 2011). 
Viruses have developed ways to overcome the autophagy pathway by 
finding ways to change autophagy activation or maturation mechanisms. It 
has been shown that RNA viruses can also use autophagy for their benefit. 
Some viruses induce autophagy, block autophagosomes from maturing, 
and uses the immature autophagosomes to replicate themselves (Deretic 
and Levine, 2009). Replicating inside the autophagosomes causes the viral 
components to be confined inside the small space to increase their 
concentration and thus increasing virus replication. Also, if the viral 
components are inside the autophagosomes, the innate immune responses 
of the host cannot detect the virus (Perot et al., 2018).  
Influenza can alter autophagy activation through a short-linear protein-
protein interaction motif in the cytoplasmic tail of the M2 ion channel protein. 
The cytoplasmic tail of M2 can directly interact with the LC3 protein, causing 
relocalization to the plasma membrane. HA proteins can undergo 
proteolytic cleavage which also increases autophagy induction through an 
unknown mechanism. Autophagy activation also increases indirectly from 
the help of viral NS1, which increases HA and M2 production. M2 can also 
interact with Beclin1, which stops the autophagosomes from maturing, 




giving rise to apoptosis (Desai, et al., 2015). This is shown in Figure 1.9. 
During IAV infection, TLR7 can detect viral PAMPs (e.g. vRNA) within 
autophagosomes (Kawai and Akira, 2010). Thus, autophagy is vital for TLR 
activation, and the induction of the host immune response. 
 
 
Figure 1.9 The IAV M2 protein blocks autophagosome-lysosome fusion. 
IAV causes the activation of autophagy, M2 blocks autophagy maturation 
and stops autophagy completion, which then induces apoptosis which 
enhances virus replication and budding (Figure modified from Rossman 
and Lamb, 2009).  
 
 




1.8 Aim of the Project 
The main aim of the project is to see what the functional differences are in 
the behaviour of IAV due to different viral morphologies. Although 
filamentous and spherical virions are favoured by different conditions, why 
one morphology is selected for is still not known. This thesis sought to see 
if morphology affected virus functions or host responses to the virus.  
Different factors, viral, physical and host, have been introduced to the cells 
to ascertain if the filamentous virions react differently from the spherical 
virions. The study will help us to better understand how the two 
morphologies function in different conditions, and to determine if filaments 


























2.1 Materials  
2.1.1 Cells, Media and Virus 
A number of different cell lines were used for this study, and these are listed 
in table 2.1.  


















A549 DMEM Rossman lab (used 
as previously 
described in 
Rossman, 2012)  
Human 
Embryonic 
Kidney Cells 293- 
with SV40 T 
antigen 
HEK 293 T DMEM Rossman lab (used 
as previously 
described in 
Rossman, 2012)  
U937 monocytic 
cells  
U937 RPMI 1640 ATCC, Virginia, 
USA (CRL-1593.2) 













Line Derived from 
Wild Type Mice 
Wild Type 
Macrophage 





Line Derived from 
TRIF Knockout 
Mice 




Line Derived from 
TRIF/TRAM 
Knockout Mice 




Line Derived from 
TRAM Knockout 
Mice 




Line Derived from 
TLR1 Knockout 
Mice 
TLR1 RPMI 1640 BEI Resources, 
NIAID, NIH (NR-
19977) 





Line Derived from 
TLR2 Knockout 
Mice 




Line Derived from 
TLR2/4 double 
Knockout Mice 




Line Derived from 
TLR3 Knockout 
Mice 




Line Derived from 
TLR4 Knockout 
Mice 




Line Derived from 
TLR6 Knockout 
Mice 




Line Derived from 
TLR7 Knockout 
Mice 
TLR7 RPMI 1640 BEI Resources, 
NIAID, NIH (NR-
15634) 





Line Derived from 
TLR9 Knockout 
Mice 




Table 2.1 Table listing the cell lines used for this study 
The cells were grown in either Dulbecco’s Modified Eagle Medium (DMEM) 
(Gibco, Fisher Scientific, Loughborough, UK) for MDCK, A549, HEK-293T 
or in Roswell Park Memorial Institute (RPMI-1640) media (Gibco) for the 
macrophage cell lines in T75 flasks. To the media 10% Foetal Bovine 
Serum (FBS) (Gibco) and 1%Penicillin- Streptomycin (Sigma-Aldrich, St. 
Louis, Missouri, USA) were added. The cells are washed with Phosphate 
Buffered Saline (PBS), and removed from the flask using TrypLE Express 
(Gibco). Cells were passaged every 2-5 days at 50-90% confluency and 
were grown at 37ºC in 5% CO2. 
Virus Name Subtype Isolation Country Collection 
Date 
A/Udorn/301/1972 H3N2 Russia 1972 
A/WSN/1933 H1N1 United Kingdom 1933 
A/California/04/2009 H1N1 California, USA 2009 
A/PR/8/1934 H1N1 Puerto Rico 1934 
 
Table 2.2. List of the viruses used in the study 




The virus strains used for the study were all provided by the Rossman lab 
and were used as previously described (Rossman, 2012). The viruses used 
are the filamentous A/Udorn/301/1972 (H3N2), its mutant spherical variant 
(M1-A41V), the spherical A/WSN/1933 (H1N1), the filamentous 
A/California/04/2009 (H1N1) and the spherical A/PR/8/1934 (H1N1). The 
virus was grown at 0.01 MOI (multiplicity of infection) on MDCK cells and 
stored at -80ºC. 
 
2.1.2 Antibodies 
A number of antibodies were used throughout the thesis. The polyclonal 
anti-Udorn goat monoclonal antibody mainly recognizes Udorn M1, NP and 
HA, with some recognition of NA and M2, was made in the lab as described 
in Rossman, 2010. The anti-LC3B mouse monoclonal antibody was 
obtained from Sigma Aldrich (ABC432). NF-kB P65 mouse monoclonal 
antibody was obtained from Santa Cruz Biotechnology (F-6 clone). 4′,6-
Diamidine-2′-phenylindole dihydrochloride (DAPI) was bought from Sigma 
Aldrich. Donkey anti-mouse and donkey anti-goat Alexa Fluor 488 and 594 
labelled secondary antibodies were attained from Thermo Scientific 
(Loughborough, UK). Cascade-blue labelled dextran (10Kda MW D1976) 
was obtained from Fisher Scientific. Alexa-594 labelled human transferrin 
(TI3343) and Fluosphere carboxylate-modified microspheres (F8803) were 
both obtained from Fisher Scientific.  
 





2.2.1 Cell Culture 
The above mentioned cells were grown in T-75 cm2 vented cap flasks 
(Sarstedt, Nümbrecht, Germany) at 37ºC in 5% CO2. They were either 
grown in DMEM (Gibco) (MDCK, A549, HEK-293T) or RPMI 1640 (Gibco) 
(all the macrophage cell lines). 10% FBS (Gibco) and 1% Penicillin-
Streptomycin (Sigma Aldrich) were added to the media. During sub 
culturing, the media was first removed carefully from the flask, and then 
washed with 5ml PBS and discarded. Then 3ml TrypLE Express (Gibco) 
was added to detach the cells from the flask. This was then incubated for 
10-20 minutes at 37ºC in 5% CO2, until all the cells detached. 7ml of the 
media was then added to the flask, and the media containing the cells was 
transferred to a sterile 15ml falcon tube (Sarstedt) and centrifuged (Heraeus 
Megafuge 40R, Thermo Scientific) for 10 minutes at 1000 RPM. The 
supernatant was then discarded, and the cell pellet resuspended in 10ml of 
the desired media and transferred to a new flask at the required 
concentration. For example, MDCK cells were subcultured at 1 in 10 dilution 
to be 90-100% confluent in 4 days.  
U937 monocytic cells are not naturally adherent and grow in suspension. 
The U937 cells were grown in DMEM media at 37ºC in 5% CO2, and when 
required plated in 6 well plates. They were treated with PMA  (Phorbol 12-
myristate 13-acetate) (Sigma-Aldrich) at 60ng/ml for 24 hours to differentiate 
into macrophages.  




2.2.2 Infection for viral stock production 
MDCK Cells were grown in T-75 cm2 flasks and infected with either 
A/Udorn/72 or Udorn-A41V. The growth media was removed from the flask 
and replaced with the virus in 3ml DMEM at 0.01 multiplicity of infection 
(MOI). Cells were then incubated for 2 hours at 37ºC, 5% CO2 with gentle 
rocking every 15 min to prevent them from drying. After the incubation, the 
media containing the virus was replaced with 12ml of serum-free media with 
1% N-acetyl trypsin (NAT) (Sigma Aldrich). The cells were then incubated 
for 2-3 days, until cytopathic effects were observed- i.e. changed 
morphology and dead cells in media. The virus was then harvested by 
taking the media in a 15ml sterile conical tube and centrifuging for 20 min 
at 1000 RPM in a Heraeus Megafuge 40R centrifuge to pellet the cell 
debris. The supernatant containing the virus was then transferred to a new 
15 ml sterile tube. This was aliquoted to cryovials at 1ml per tube and stored 
at -80ºC for further analysis.   
For the different analysis, different MOIs of the virus are used, and they are 
mentioned in each of the experiments.  
 
2.2.3 Plaque Assay 
Plaque assays were used to check the viral titre after each infection 
passage. MDCK cells were grow in 6 well plates, with 90% confluency. A 
serial dilution of 10-2 to 10-7 was prepared with 1% BSA in DMEM. The 
media from the wells was aspirated, and the cells washed with PBS. 400µl 




of the correct virus dilution was added to the wells and then incubated for 2 
hours at 37ºC at 5% CO2 with gentle rocking every 15 min to prevent them 
from drying. After the incubation, the media was removed from the wells 
and replaced with replacement media containing 50% Avicel (Sigma 
Aldrich) and 50% 2x DMEM (with 2µg/ml NAT). The Avicel works as an 
overlay media similar to agarose and restricts free virus spread, enabling 
localised plaque formation. The plates were incubated for 3 days at 37ºC 
and 5% CO2, until the plaques could be observed. After the incubation, the 
wells are stained with crystal violet (0.1% naphthalene, 4% glacial acetic 
acid, 1.36% anhydrous acetic acid with 92.5% water) overnight and the 
plaques counted the next day. The plaque assays were done in duplicates, 
and the virus titre was calculated by the equation: 
 
Viral Titre =    Number of plaques     
  Dilution x volume of virus added to the well (ml) 
 
The unit for the virus titre is Plaque Forming Units (PFU) per ml. 
 
2.2.4 Purification  
For purification, the virus (Udorn or A41V-Udorn) at 0.001 MOI was grown 
on MDCK cells as described above. The viral supernatant (12ml) was then 
harvested and placed in a centrifuge tube over a 1ml 60% Optiprep Density 
Gradient Medium (Sigma-Aldrich) cushion. This was ultracentrifuged 
(Optima LE-80K, Beckman Coulter, California, USA), at 24000 RPM for 1 
hour at 4ºC, in a SW28 rotor. This formed a band at the bottom, containing 




all the virus. The bottom 2 ml, including the band is taken and added to 10 
ml of PBS. This was then placed over an Optiprep gradient, made by adding 
PBS, and making a series of concentrations from 60%-15% Optiprep. 
Again, the tubes were ultracentrifuged at 24000 RPM for 1 hour at 4ºC. This 
formed three separated bands in between the gradients. The different 
morphologies have different densities which causes them to form separate 
bands in between the different densities. These were obtained using a 
syringe and stored at -20ºC.  
 
2.2.5 Immunoblotting 
For immunoblotting, cells were plated in 6 well plates and grown overnight 
and infected with IAV at 1 MOI for the indicated timepoint. The cells were 
lysed post infection in a NuPAGE MES SDS Laemli Sample Buffer (1X) 
(Thermo Fisher) and were prepared according to the protocol of Bolt Bis-
Tris Plus Mini Gel Electrophoresis System (Life Technologies). Lysates 
were first heated to 90ºC, and 20µl of each sample per well was loaded to 
the Mini-PROTEAN Any kDa precast gels (Bio-Rad, California, USA). One 
of the wells was loaded with 10µl SeeBlue Plus2 Pre-stained protein 
Standard (Novex, Life Technologies, California, USA). By using an EC570-
90 Power supply (Thermo EC), the gel was run at 160V for 40 mins. The 
proteins were then transferred to a polyvinylidene difluoride (PVDF) 
membrane (iBlot Dry Blotting System, Life Technologies) using the iBlot Gel 
Transfer Device (Life Technologies). The membrane was first blocked by 




incubating in blocking buffer (5% dry milk in PBS with 0.1% Tween-20) for 
1hr. Viral proteins were then detecting using immunoblotting with the anti-
Udorn primary antibody at a 1:200 dilution in blocking buffer for 1hr. They 
were then washed with PBS. Next, a donkey anti-goat secondary antibody 
conjugated with horseradish peroxidase (HRP) (Thermo Fisher Scientific) 
at a 1:1000 dilution in blocking buffer was added for 1hr. They were then 
washed 4x 5min PBS + 0.1% Tween-20. The blot was then treated with 
Western Breeze Chromogenic Immunodetection kit (Invitrogen, California, 
USA) before visualization on the SynGene G Box F3- Gel Imaging for 
Fluorescence and Visible Application. 
 
2.2.6 Protein Quantification Assay 
The three separated layers from the virus purification (spherical, 
filamentous and debris) were used to set up a Protein Quantification Assay, 
as described in the protocol of Pierce™ BCA Protein Assay Kit (Thermo 
Scientific). A series of standards were prepared by mixing albumin standard 
ampules with PBS. 25µl of the standards and samples were set up in a 96 
well plate, in triplicates, and then 200µl of the working reagent (50:1 of BCA 
A with BCA B) was added to them. Then the plate was put on a shaker for 
30 seconds, followed by 30 minute incubation at 37ºC. The plate was left 
to cool to room temperature, and then read on a CLARIOstar plate reader 
(BMG Labtech, Aylesbury, UK) at 562 nm. The protein concentration of the 
standards was plotted against absorbance using Microsoft Excel in order to 




generate a standard curve. The results from the samples were then 




The separated bands form the virus purification utracentrifugation assay 
were negatively stained with 1% Phosphotungstic Acid (PTA) for 30 
seconds before absorption to TEM grids and imaging. Freshly glow 
discharge treated 400 mesh copper grids were used and were provided by 
the Biomolecular Imaging Facility. Samples were imaged on a JEOL 1230 
(Tokyo, Japan) electron microscope using a Gatan 831digital camera 
(Pleasanton, California, USA). The percentage of filamentous virions was 
calculated following TEM imaging of A/Udorn/72 supernatant. Virions 
termed filamentous possessed lengths greater than 250 nm. Image 
processing was limited to cropping and equal adjustment of image levels.  
 
2.2.8 Immunofluorescence 
Cells were grown on sterile coverslips in 6 well plates before being infected 
as described at different MOIs (0.1, 0.5, 1 or 3 MOI) for the indicated time. 
Cells were fixed in 10% formalin for 10 min at room temperature and 
permeabilised with 0.4% Triton X-100 (Bio-Rad) for 15 min. The coverslips 
were then blocked with PBS containing 1% BSA for 30 min before 




incubation with the indicated primary antibodies at 1 in 200 dilution in PBS 
+ 1% BSA for 1 hour at room temperature, followed by washing 4 times with 
PBS. Alexa-labelled secondary antibodies were then added at 1 in 1000 
dilution in PBS + 1% BSA, and covered as they are light sensitive, and 
incubated for 1 hour at room temperature. Again, cells were washed 4 times 
with PBS, and blotted dry before mounting on glass slides using Prolong 
Gold (Invitrogen), and left overnight to dry before they were viewed with 
epifluorescence microscopy (LumaScope, Etaluma, California, USA) or 
confocal microscopy (Zeiss LSM 880 with Airyscan, Oberkochen, 
Germany). 
For the entry pathway analysis, freshly split RAW Blue cells with 5 × 105 
cells per sample, were resuspended in 1 ml DMEM and 10% FBS at 37°C. 
Cascade-blue dextran (1mg/ml), Alexa-594-Transferrin (50ug/ml) , and 
FluoSpheres (1x108)  were added to the cells.  To this 3 MOI of Alexa-488-
A/Udorn/72 labelled with vibrant DiD in DMSO (1x106 PFU/ml) was added. 
The samples were gently shaken at 37°C in sealed tubes for 0-60 minute. 
Sample uptake was then stopped by the addition of ice-cold PBS. Samples 
were washed 3 times with cold PBS, fixed with 4% formaldehyde for 15 min, 
pelleted, and washed 3 times with PBS. Cells were then viewed on a Zeiss 
LSM 880 confocal microscope to detect virus entering cells by 








2.2.9 Confocal Microscopy 
Confocal microscopy was performed using the Zeiss LSM 880 confocal 
microscope with a plan-apochromat 63x objective (Zeiss) using Zeiss Zen 
software and automatic image setting parameters. For NF-kB p65 imaging, 
single Z-sections through the cell mid-plane were used and Zen software 
was used to define the nucleus and then compare the intensity of p65 
fluorescence in the nucleus and cytoplasm. For entry pathway analysis, 
Airyscan detection was used with Z-section 3D imaging.  
 
2.2.10 QUANTI-Blue NF-kB Activation Assay 
96 well plates were set up as described in the manual provided by the 
QUANTI-Blue (InvivoGen). QUANTI-Blue is designed to detect secreted 
embryonic alkaline phosphatase (SEAP) that is produced under control of 
a NF-kB responsive promoter. RAW Blue cells (InvivoGen) were grown as 
described and were treated with CPZ (20uM) and/or EIPA (80uM) (both 
from Sigma Aldrich) for 1 hour, and then infected with either Udorn or M1-
A41V at 3 MOI for 1 hour. 200µl of QUANTI-Blue was added to the plate, 
and 20µl of the pre-treated RAW Blue cells were added to them. This was 
then incubated for 30 minutes at 37°C. After the incubation, the plates were 
read on a CLARIO-star (BMG Labtech) plate reader at 620 nm. The results 
were used to plot a graph in Excel showing the absorbance for each of the 
conditions and required calculations, including Student’s T Test to look at 
the significant differences, were carried out. 




2.2.11 IncuCyte Autophagy Activation Assay 
IncuCyte live cell imaging plates were set up with A549 cells that stably 
express the autophagy sensor LC3-mCherry-eGFP as described by 
IncuCyte (Essen Biosciences, Ann Arbor, MI). Cells infected with either 
filamentous Udorn or spherical PR8 viruses at 1 or 5 MOI and live imaged 
on the IncuCyte Zoom imaging system 37°C with images taken at 10x every 
1 min for 120 min. Live images were processed using IncuCyte software to 
calculate and display eGFP and mCherry fluorescence over time for each 
condition. 
  2.2.12 UV Inactivation of Virus 
IAV was grown as previously described and taken in a sterile petri dish and 
were subjected to UV radiation at 254 nm for 30 minutes. This makes the virus 
lose its infectivity. The UV inactivated virus was used in plaque assays to 

























3.1 Purification of Influenza Virus Morphologies 
3.1.1 Introduction 
Influenza virus can display various morphologies, ranging from spherical, 
ellipsoidal and filamentous, although some random shapes can also be 
sometimes observed (Noda, 2012) (Calder et al., 2011). However, the 
spherical and filamentous shapes are the most commonly seen. The 
spherical viruses, as named are spherical structures, and are usually 120 
nm in diameter. The filamentous structure is more elongated, and they can 
be a few micrometres long, but normally they go up to 1µm. However, the 
diameter remains 100-120 nm. The spherical structure is more common in 
the laboratory grown strains, while the filamentous are observed more in 
samples from clinical isolates (Elton et al., 2013). Many different viral and 
host factors can influence the structure to be either spherical or filamentous. 
The virus undergoes mutations to adapt to the different environments and 
thus their phenotype changes accordingly (Elton et al., 2013).  
The first part of the experiments was to determine that A/Udorn/72 strain is 
actually pleomorphic, and that it was indeed worth using Udorn and its 
mutant, M1-A41V, to determine the differences in spherical and filamentous 
virus. The Udorn strain can retain its filamentous morphology during 
passages. However, when there is a single point mutation of its M1 protein 
at position 41 from alanine to valine, the Udorn strain completely loses its 
ability to form filaments, and only forms spherical virions (Campbell et al., 
2014). 





3.1.2 Results: Purification of spherical and filamentous 
influenza viruses 
To determine the morphology of Udorn, the viruses were grown in MDCK 
cells and harvested. They were then separated by ultricentrifugation to look 
at the difference in morphology and to separate the spheres from the 
filaments. This was done by setting up an iso-osmotic gradient of Optiprep, 
followed by ultracentrifugation at 24000 RPM for 1 hour at 4°C. This 
separates the filaments from the spheres, and they accumulate in separate 
bands within the media, due to their different densities.  
Figure 3.1 shows the separated bands after ultracentrifugation. The 
spheres have the lowest density and settle at the top layer. Filaments have 
a higher density than spheres and accumulate in the second layer. The third 
layer only comprises of cell debris.  















Figure 3.1 Separation of Influenza A virus (Udorn) morphologies. Udorn 
grows as a mixture of filamentous and spherical virions. MDCK cells were 
infected with the virus at 0.001 MOI and left for 48hours. The supernatant 
was then collected and ultracentrifuged at 24000 RPM for 1 hour on an 
Optiprep gradient, to separate the filaments from the spheres. The 
gradients were set up at a series of densities (from 60% to 7.5%). The 
different morphologies have different densities which causes them to settle 
in between the Opriprep gradient that can then be extracted.  
 
 




3.1.3 Results: Analysis of purified fraction 
IAV are pleomorphic and can express different morphologies. The assays 
above were used to show that the strain used, A/Udorn/72 does indeed 
consist of both spherical and filamentous virions and these can be 
separated using ultracentrifugation. The separation with ultracentrifugation 
depends on the density, and thus it forms three distinct layers, which can 
be separated and analysed. To confirm the separation of filaments and 
spherical virions, the layers were extracted from the gradient, separated 
and subjected to TEM (Figure 3.2 and 3.3), protein quantification (3.4) and 
immunoblot (Figure 3.5) analysis.  
To determine virus morphology, purified fractions were subjected to 
negative staining and visualization by TEM. TEM analysis showed 
successful separation of filamentous and spherical virions (Fig. 3.2 and 
3.3). The protein quantification assay was used to calculate the total 
amount of protein present in each of the virus fractions (Figure 3.4) whereas 
immunoblotting was used to show the presence of the specific viral proteins 
in the separated bands (Figure 3.5). 
The protein concentration assay shows that all the three layers contain 
comparable amounts of protein, but it is not possible to determine what they 
are from this assay. Immunoblot analysis was done further on the bands, 
and these show that the top and middle band contains most of the viral 
proteins, thus confirming that these fractions contain the purified viruses. 




Although the bottom band contains some viral protein, the amount is 
















Figure 3.2 Pleiomorphic morphology of A/Udorn/72. The separated bands 
following ultracentrifugation purification were observed following negative 
staining and TEM imaging. Figure a and b shows the constituents of the top 




band, and mostly spherical structures can be observed. Figure c and d are 
taken from the middle band, and mostly filamentous structures can be seen, 
although a few spheres are also observed. Due to the high forces present, 
some of the filaments can disintegrate or curl up as seen in the images. 
Figure 2e and 2f show the bottom band which is filled with debris that lacks 
the outer spiky layer of Haemagglutinin and is significantly larger or smaller 
than 100nm virions.  
 
TEM was used to further confirm the results, that the bands actually show 
the separated morphologies. For A/Udorn/72 (Figure 3.2) it was seen that 
the top band consisted mostly of the spherical virions. The middle band 
consisted of filaments. These filaments however curl up and disintegrate 
because of the very powerful ultracentrifugation process, and thus cannot 
be further used to infect cells. The third band mostly shows debris. These 
assays helped to show that Udorn actually consists of both filamentous and 
spherical virions, and thus were used in the following experiments. In case 
of M1-A41V, it still formed 3 layers, but in the middle layer, unlike Udorn, 
the virions look similar to the spherical virions. They are slightly bigger in 






















Figure 3.3 M1-A41V does not form filamentous virions. M1-A41V virus 
grown at 0.001 MOI on MDCK cells, were subjected to ultracentrifugation 
on an optiprep gradient. The virions separated to form 3 layers. The upper 
layer showed spherical virions (a and b). The middle layer showed slightly 
larger virions, which looks like bacilliform (c and d). The last layer consisted 
of debris (e and f). This shows that unlike, A/Udorn/72, filaments do not 
form in M1-A41V. 












Figure 3.4 Protein concentration of the separated bands of A/Udorn/72 and 
M1-A41V. A BCA protein concentration assay was carried out on the 
samples from the three bands. This was done on a 96well plate with a 
Pierce BCA Protein Assay Kit, as shown in a. The results were read on a 
plate reader, and a BSA standard curve was plotted in Microsoft Excel. The 
gradient of the curve was calculated and used to calculate the 
concentrations for the separated bands as shown in the table. 
Udorn Absorbance    Protein 
Top band 1.077 828.4615 
Middle Band 1.567 1205.385 
Bottom Band 1.5005 1154.231 
M1-A41V Absorbance    Protein 
Top band 
      0.1751717        134.74747 
Middle Band 
    0.136697        105.15152 
Bottom Band 














BSA Standard Titration a b 









Figure 3.5 Protein contents of A/Udorn/72 fractions. Extracted fractions 
were subjected to SDS-PAGE and immunoblotted with the anti-Udorn 
antibody, showing the bands for HA (75kDa), NA (55kDa) and M1(26kDa) 
from each separated fraction.  
 
3.1.4 Summary 
From previous studies we know that A/Udorn/72 is pleomorphic in nature, 
and its mutant M1-A41V only forms spherical virions; however, we first 
sought to confirm this before using the strains for all the further 
experiments. The results from the immunoblot analysis and TEM confirm 
that Udorn does indeed form filamentous and spherical virions. The results 
also show that the morphologies can be separated, due to their difference 
in density. Although the harsh process of separating them breaks the 
filaments, hopefully fewer harming techniques will be discovered in the 
future to separate them, so that studying the difference between spheres 
and filaments become easier. 
 




3.2 Priming of Host Cells by infecting with UV treated Virus 
3.2.1 Introduction 
It is essential for the IAV infection to spread for their growth and survival, 
and this is aided by their budding process. The infection can either spread 
from one cell to another or they can spread in between different hosts. It 
has been suggested that many filaments may not complete the budding 
process but may be there to aid in infection of other virions (Badham and 
Rossman, 2016). Budding IAV filaments are long enough that they can 
easily contact a neighbouring uninfected cell. Given that viral contact 
triggers the induction of macropinocytosis (Badham and Rossman, 2016) if 
a filament contacts a neighbouring cell, the upregulation of 
macropinocytosis may prime the cell to take up other free spherical or 
filamentous viruses that it next encounters (Badham and Rossman, 2016). 
So, these ‘non-infectious’, long and thin filaments may prime the cells 
beforehand for other infectious virions. For these reasons it was thought if 
cells were primed it would help IAV infection to work better and more 
efficiently, which may explain a function of the filamentous morphology, as 








Figure 3.6 Priming of host cells may enhance IAV infection. Schematic 
diagram to show that the long, thin filamentous virions can come in contact 
with multiple cells at the same time. This binding increases the chance of 
macropinocytosis activation to occur. This may help more spherical and 
filamentous virions to enter the cells, and thus increasing the chance of 
infection. Spherical virions do not come into contact with multiple cells at 
the same time to induce macropinocytosis. For this reason, it was 
hypothesised that filaments can prime cells before infection, to make the 









3.2.2 Results: Filamentous virion priming of infection 
As it was hypothesised that non-infectious filamentous IAVs can prime 
cells, the virus was inactivated with UV treatment. Both Udorn and control 
spherical M1-A41V virions were subjected to UV radiation at 254 nm for 30 
minutes. Subjecting to UV treatment damages the RNA genome, thus 
inactivating the virus; but in turn they can act as mimics of the non-infectious 
filamentous virions. To confirm UV inactivation, plaque assays were carried 
out. Plaque assays are the standard method to check infectious virus 
concentration by measuring the plaque forming units (pfu) of the sample 
virus. The results for both Udorn and M1-A41V are given in Figure 3.7. 
Figure 3.7a shows results from untreated M1-A41V virus where the titre 
was 1.1x106 pfu/ml. Figure 3.7b shows the result for UV treated M1-A41V. 
Even in the first well, there is no plaques, so the concentration is 0 pfu/ml. 
Figure 3.7c, shows the plaques for A/Udorn/72, with a titre of 5.0x105 pfu/ml 
In Figure 3.7d, when the same virus is inactivated with UV treatment, it 
again fails to form plaques and the titre is 0 pfu/ml. Although the untreated 
virus of the same source forms plaques as normal, when they were UV 
inactivated, they lose their ability to form plaques, i.e. the UV treatment did 
indeed inactivate both Udorn and M1-A41V successfully. This is shown in 
more details in the ‘Appendix’ section. 
As it was confirmed that the treated viruses lose their ability to infect, they 
were next taken to check if non-infectious filamentous or spherical virus can 
indeed prime cells for better infection. To test this, MDCK cells were grown 
on 6 well plates, and first ‘infected’ with the UV inactivated virus for 1 hour 




at 1 MOI. This was then followed by infection with untreated virus again at 
1 MOI, for 4, 6, 8 and 18 hours. The infected cells were then lysed and 
immunoblotted to check the changes in IAV protein expression over time. 
The results are shown in Figure 3.8, which shows that over time, when the 
cells were infected with UV treated virus only, the viral proteins decreases. 
This happens because the virus enters the cells, but the cell degrades them 
over time and no viral proteins are being expressed. No subsequent viruses 
are being formed, as they fail to infect and replicate, the viral proteins are 
no longer seen at the longer infection timepoints. However, the results also 
do not show any differences between the viral protein expression levels, 
when the cells were primed first with inactivated virus, as compared to just 
infection with untreated virus. This suggests that previous IAV contact does 
not prime cells to better activate macropinocytosis and enhance virus 
infectivity.  
To confirm these results further, Epifluorescence Microscopy was used 
(Figure 3.9) to check if any differences in viral protein distributions could be 
spotted between the different conditions. MDCK cells were again infected 
with UV inactivated virus for an hour at 1 MOI, followed by infection with 
untreated virus at 1 MOI for 6, 8 and 18 hours. The cells were then fixed 
and stained with an anti-Udorn antibody, followed by Alexa-488 secondary 
antibodies and epifluorescence imaging. The results confirm that UV 
treatment of virus eliminates its ability to productively infect cells, 
irrespective of the incubation time. The results also show that priming of 




cells with UV treated virus, before infection, does not show any difference 
in infection. 
Following this, Epifluorescence Microscopy was again used to check if 
there is any difference in priming ability due to the morphology of the 
priming and infecting virus, using A/Udorn/72 and M1-A41V (Figure 3.10). 
MDCK cells were once again infected with UV treated Udorn or M1-A41V 
at 1 MOI for 1hour. This was followed by infection with the untreated Udorn 
or M1-41V at 1 MOI for 8 hours. The cells were then prepared for 
immunofluorescence microscopy by staining with anti-Udorn antibody as 
before. The cells were then mounted in the presence of DAPI and viewed 
with an epifluorescence microscope. The results show that there was no 
difference between M1-A41V and A/Udorn/72 in terms of priming or 
infectivity. Priming with filamentous or spherical UV inactivated virus 
beforehand does not show any difference in subsequent infectivity of either 
filamentous or spherical virions. However, in both cases it was noticed 
instead of aiding infection, as was hypothesised, the expression of viral 
proteins decreases for both filaments and spheres. This means that priming 
with inactivated virus is not actually helping the virus to enter cells better 
but is actually inhibiting viral entry. 
 
 





Figure 3.7 Plaque assay to confirm UV inactivation of Virus. To inactivate 
the virus, viral stocks were exposed to UV radiation for 1/2 hour at 294 nm. 
This inactivated virus was then used to infect MDCK cells in a 6 well plate, 
at 1 MOI for 48 hours. To compare the results, MDCK cells were also 
infected at the same conditions with untreated virus, from the same source. 
As shown in ‘a’, with wild type M1-A41V infection, plaques form as normal. 
However, when the same virus strain is UV treated, it loses its ability to form 
any plaques (‘b’). This is also seen when infected with Udorn; when infected 
by wild type plaques form (‘c’) as usual but are unable to form then when it 
is UV treated (‘d’). 
 
 






Figure 3.8 UV inactivation disrupts viral protein synthesis. Immunoblot 
results to show the effect of UV inactivation on viral protein expression after 
different hours of infection. For UV priming, MDCK cells were grown in 6 
well plates, and first treated with UV inactivated virus for 1 hour. The cells 
were then washed with PBS and again infected with the normal untreated 
virus. They were infected for different time points, to look at differences in 
infection due to time. ‘A’ shows results for infection of cells with first UV 
inactivated virus followed by untreated virus, ‘B’ shows results for infection 
with only UV inactivated virus and ‘C’ shows results from infection with only 
untreated virus. The viral proteins can be seen in the early hours after 
infection, but at later hours protein synthesis is disrupted in UV inactivated 
virus. No difference can be spotted in viral proteins due to priming of cells, 
before infection.  





Figure 3.9 Infectivity differences following virus priming over time. 
Epifluorescence microscopy was used to check if there are any difference 
in infectivity due to priming of MDCK cells, at different time points. MDCK 
cells were first infected with UV treated virus for 1 hour at 1 MOI. This was 
followed by infection with untreated A/Udorn/72 at the same MOI for 6, 8 
and 18 hours. Figures ‘a’, ‘d’, and ‘g’ are showing results for infection with 
untreated A/Udorn/72 only; ‘b’, ‘e’ and ‘h’ are showing results for infection 
with UV treated virus, followed by untreated virus; ‘c’, ‘f’ and ‘i’ are showing 
results for infection with UV treated virus only. The cells were stained with 




anti-Udorn antibody and Alexa-488 labelled secondary antibodies before 
visualisation. The scale bar shows 10um. 
 
Figure 3.10 Morphology effect on MDCK cell priming with UV inactivated 
Virus. MDCK cells were infected with UV inactivated virus (either 
A/Udorn/72 or M1/A41V) at 1 MOI for 1 hour. This was then infected with 
untreated Udorn or A41V virus at 1 MOI for 8 hours. The cells were then 
prepared for immunofluorescence by staining with anti-Udorn antibody and 
viewed with epifluorescence microscopy. In ‘a’ the cells were infected with 
only M1-A41V or A/Udorn/72, in ‘b’ they were first infected with UV treated 
M1-A41V or A/Udorn/72 followed by infection with the same untreated virus, 








3.2.3 Summary  
Filaments are long and thin and can come in contact with multiple host cells 
at the same time, even during the course of virus budding. This can 
potentially induce macropinocytosis and thus the cells can engulf other IAV 
virions at a greater rate (Badham and Rossman, 2016). It was thought that 
some filamentous virions are never released from the infected cell, and their 
only purpose may be to induce macropinocytosis in neighbouring cells 
(Badham and Rossman, 2016), thus priming the cells for infection, and 
making the viral infectivity process much faster and more efficient. 
To test this hypothesis, cells were infected with UV inactivated virus, before 
infecting with untreated virus. UV treatment of the virus damages their RNA 
genome; thus, they lose their ability to productively infect cells. The cells 
were first treated with UV inactivated virus, which acted like the ‘un-
infectious’ filamentous virions, to prime the cells for latter infection. The cells 
were then treated with untreated virus, and the results were viewed with the 
help of immunoblotting and epifluorescence microscopy. 
From both assays, the results concluded that priming of host cell prior to 
infection, with UV inactivated virus, does not aid and make infection quicker. 
The infection for both Udorn and A41V did not show any differences due to 
priming. This means the infectivity of both Udorn and A41V are the same, 
and priming does not assist the filaments in any way as it was hypothesised.  
However, it was noticed from the assays that in both filamentous Udorn and 
spherical A41V, if the host cells were primed beforehand, then infectivity 




was reduced. This suggests that instead of making the whole process faster 
and more efficient, as it was thought, priming actually decreases virion 
infectivity through an unknown mechanism. This mechanism may be that 
priming causes the innate antiviral proteins to activate faster and more 
easily. It also may be due to the factor that macropinocytosis causes a 



















Chapter 3.3 Differences in Host Factors can affect the activity 
of viral morphologies 
3.3.1 Introduction 
Host factors seem to play an important role in determining the morphology 
of the virus. The immune system of the host, both innate and adaptive, also 
plays an active role in viral infectivity and replication and thus may be 
affected by virus morphology (Fukuyama and Kawaoka, 2011). The innate 
immune system is the first line of defence against IAV, and the following 
experiments will be looking at differences in infectivity of IAV due to host 
cell factors, and how they can differ between the two morphologies. 
 
3.3.1.1 Differences in NFkB expression due to IAV morphology 
NF-kB is one of the most important regulators of the innate immune 
response of hosts and is sometimes termed as the central mediator of 
immune responses (Hiscott et al., 2016). It plays an important role against 
viral infection, and thus viruses have evolved to work around the NF-kB 
pathway for better infection progression. During influenza virus infection, 
viral proteins interact with the host proteins and use them for their own 
benefits, including the NF-κB signalling cascade. NF-κB signalling is 
essential for the host immune response, and the viral proteins manipulate 
the molecular function of the signalling molecules involved to assist in their 
pathogenesis (Nimmeriahn et al., 2004). Figure 3.11 shows the NF-kB 




pathway, which gets activated when TLRs recognise PAMPs (TLR7 for 
IAV), which may be presented to them in endosomes or autophagosomes. 
As TLRs respond to PAMPs in internal vesicles and filaments and spherical 
virions enter cells by different endocytic pathways, it is possible that 
morphology can affect TLR and subsequently NF-kB signalling at early 
stages of infection.  
 
Figure 3.11: Diagrammatic representation of the innate immunity pathways 
of the host cell leading to pro-inflammatory cytokine production. The TLR 
comes across a pathogen, it triggers the NF-kB pathway which causes the 
NF-kB to get activated and produce pro-inflammatory cytokines (figure 
modified from O’Neill, Gollenback and Bowie, 2013).  




3.3.1.2 Results: NF-kB activation 
To check if there is a difference in NF-kB activity due to the difference in 
morphology, during early infection, epifluorescence and confocal 
microscopy were used. MDCK cells were grown in 6 well plates and were 
infected with A/Udorn/72 or A41V cells for 1 hour at 3 MOI. The infected 
cells were then stained with anti NF-κB (p65) and anti- Udorn antibodies, 
before being mounted with DAPI and observed by immunofluorescence 
microscopy.  
In figure 3.12, NF-kB is shown in green, the virus (A/Udorn/72 or M1-A41V) 
is shown in red and the MDCK cell nucleus is shown in blue (DAPI). It can 
be seen that when infected with M1-A41V, NF-kB traffics to the nucleus of 
the cells. However, this cannot be seen when the MDCK cells were infected 
with Udorn. When infected with Udorn, the NF-kB does not enter the 
nucleus but remains at its periphery. This suggests that when infected with 
A/Udorn/72, NF-kB fails to get activated. However, NF-kB does get 
activated when infected with the spherical virus M1-A41V. This means that 
filaments are somehow preventing NF-kB activation, and thus it does not 
enter the nucleus.  
To confirm these results, the experiments were repeated on different cell 
lines, including immune cells that exhibit robust innate antiviral immunity 
and starting with U937 cells. U937 cells are human monocytes from 
lymphoblasts, and when treated with PMA they differentiate to form 
macrophages. They were infected and stained in the same method as 




before and observed by epifluorescence microscopy. The results are 
shown in Figure 3.12, which again confirms that filaments somehow block 
the activation of NF-kB. Again, it can be seen that in A/Udorn/72 NF-kB 
remains in the cytoplasm, while when infected by M1-A41V, NF-kB enters 
the nucleus. This again shows that spheres facilitate NF-kB activation, but 
filaments somehow prevent this.  
To test if this happens on multiple cell lines, the experiments were again 
repeated on different cell lines. Human epithelial 293T and A549 cells were 
infected at 1 MOI with either Udorn or M1-A41V for 1 hour, and again 
stained with the same antibodies, and were compared with MDCK results. 
This time confocal microscopy was used to look at the cells. As seen in 
Figure 3.13, the difference between M1-A41V and Udorn is hard to see in 
both 293T and A549 cells. Although, some NF-kB nuclear localization can 
be seen in A549 cells infected with M1-A41V, but it cannot be seen in 293T 
cells. This means that NF-kB nuclear localization during spherical virus 
entry is not universal for all cells, and that IAV activation of NF-kB varies in 
different cell lines.  
 














Figure 3.12: Nuclear Localization of NF-kB in MDCK cells. MDCK Cells 
were either infected with A/Udorn/72 or M1-A41V at 1 MOI for an hour. Anti-
NF-kB (p65) (green) and anti-Udorn antibodies (red) were added to the cells 
and imaged by epifluorescence. MDCK cell nuclei are show in blue (DAPI). 
As it can be seen from the staining, NFkB is localized in the nucleus of the 



















Figure 3.13 Confocal images showing the difference in nuclear localization 
of NFkB in different cell lines. The cells were infected with either A/Udorn/72 
or M1-A41V at 1 MOI for 1 hour. They were then stained with anti-Udorn 
antibody (red) and anti-P65 for NF-kB (green). The cell nuclei are shown in 
blue (DAPI). As can be seen in image 3.15a (293T cells) and 3.15b (A549 
cells), the difference between the spheres and filaments are not really 
noticeable, but in case of MDCK cells, as shown in Figure 3.15c, the 
difference is more dramatic. In MDCK cells, when infected with A/Udorn/72, 
NF-kB fails to enter the nucleus, but when infected with M1-A41V it enters 
the nucleus. This difference is not noticeable in A549 or 293T cells. The 




















Figure 3.14 Epifluorescence Images of NF-kB nuclear localization in U937 
cells. U937 cells were differentiated with PMA and grown on 6 well plates 
and infected with either A/Udorn/72 or M1-A41V at 1 MOI for 1 hour. They 
were then stained with anti-P65 (NF-kB) antibodies (green). The cells were 
mounted with DAPI (blue) and imaged. It can be seen that when infected 
with M1-A41V, NF-kB enters the nucleus, but fails to do so when infected 
with the filamentous A/Udorn/72. The scale bars show 10 um. 
 








3.3.1.3 Results: quantification of NF-kB nuclear localization 
Zen Blue software was used to quantify the results from confocal 
microscopy by measuring fluorescent intensity in different regions of the 
cell. This was done as shown in Figure 3.15. For the different cell lines and 
viral infections, the ratio of intensity of Nf-kB (in green) was calculated in 
the cytoplasm and the nucleus. This was done by drawing outlines around 
the cytoplasm and the nucleus of specific cells, and using the software to 
calculate the ratio of fluorescence intensities, which can then be plotted. 
Figure 3.16 shows the difference in NF-kB localization in MDCK and A549 
cells, after infecting with either Udorn or A41V. Unfortunately, due to 
equipment failure, the U937 results were only looked at with 
epifluorescence microscopy, thus similar calculations could not be done. 
As can be seen from the graph, there is a definite difference in the NF-kB 
localization between A41V and Udorn infection in MDCK cells, but this is 
not noticeable in A549 cells. This is further confirmed by doing a student’s 
unpaired T test, which shows that the difference in MDCK cells between 
Udorn and M1-A41V is less than 0.05, thus there is a significant difference. 
However, in A549 cells there is no significant difference between the two. 
 







Figure 3.15 Quantifying NFkB localization from the confocal images. First 
a circle is drawn around the nucleus, and then another is drawn around the 
cytoplasm. The program gives the intensity in that area automatically, and 
from that the ratio can be found, for each of the cells. An average was 
calculated from the total number of cells of each condition and the average 
calculated, and data graphed and analysed by a Student’s T-test. 
 
 









Figure 3.16 Graph showing that NFkB nuclear localization due to different 
IAV morphologies varies in different cells lines. The results from Figure 9 
can be further confirmed from the results of the quantification. As shown in 
MDCK cells the difference in NF-kB nuclear localization between spheres 
and filaments is much greater than in A549 cells. A Student’s unpaired T 
Test was carried out, which confirms that in MDCK cells, the difference 
between A/Udorn/72 and M1-A41V is significant, but not in A549 cells. For 
each cell type 42 cells were considered. The error bars are showing the 



















































To confirm the difference in NF-kB activity in the different cell lines, the 
experiments were repeated in RAW Blue cells. These are a mouse 
macrophage reporter cell line, which express a secreted embryonic alkaline 
phosphatase (SEAP) which is induced by NF-kB activity. Macrophages are 
one of the first responders of IAV infection, and the virus is capable of 
directly infecting these cells (Cline, Beck and Bianchini, 2017). NF-kB is 
one of the key responders of macrophage, and thus macrophages may give 
one of the highest levels for NF-kB activation when infected with IAV. It was 
noticed before that the NF-kB nuclear localization is best seen in 
macrophages (U937 and mouse macrophages), and thus this cell line was 
used to further confirm the results. Quanti Blue analysis was used to 
compare the results, shown in Figure 3.17. Quanti Blue is a colourimetric 
assay to detect Alkaline Phosphatase activity. The RAW Blue cells infected 
with either Udorn or M1-A41V were added to a 96 well plate, and Quanti 
Blue was added to them. The change in colour was read by a plate reader, 
and the results exported to Excel for graphing. LPS was used as a control, 
as it is a known robust activator of TLR4 and NF-kB in macrophages. It was 
noticed that at high (3) MOI infections, the difference in NF-kB nuclear 
localization is not very noticeable between Udorn and A41V. However, at 
low (0.5) MOI infectious, the difference is significant between Udorn and 
A41V. A Student’s unpaired T Test was used to confirm the results, and it 
shows that in low MOI, there is a significant difference in Udorn vs M1-
A41V. Although the p value is <0.05 for high MOI, but from the results it can 
be seen that NF-kB nuclear localization is higher in Udorn when compared 




to A41V, so this is not considered. When the values were again scrutinised 
for high MOI, it did not show much difference between A41V and Udorn, 
suggesting that at high MOI, there is no significant difference in the two 
conditions. The calculations of the T test are shown in the ‘Appendix’. This 
further confirms our theory that filaments somehow block NF-kB activation 
and nuclear localisation. 
 
        Student’s unpaired T Test 
 
 
Figure 3.17: Quanti Blue results to show the difference in NF-kB activation 
between Udorn and A41V in RAW Blue Cells. In the RAW blue cells, the 
differences in NF-kB activation are greater with a lower MOI infection (0.5 
MOI). As can be seen from the graph, there is a large difference between 



































NF-kB activation Udorn low-MOI and A41V low-MOI, which again shows 
that NF-kB gets activated and traffics to the nucleus during sphere 
infections, but not with filaments. This was confirmed by a Student’s 
unpaired T Test, which confirms that in low MOI there is a statistically 
significant difference between Udorn and M1-A41V NF-kB activation, 
shown by the asterisks which indicate a p<0.0005. For each condition 




So far, all the assays were performed using Udorn and M1-A41V viruses. 
This does not let us know if the difference in nuclear localization of NF-kB 
is exclusive to Udorn and its mutant strain or is a general property of virus 
morphology. To test this, the experiments were repeated with different IAV 
strains- A/WSN/33, A/PR/8/34 and A/Cal/09. A/WSN/33 and A/PR/8/34 are 
spherical strains while A/Cal/09 is a filamentous strain. Figure 3.18 shows 
the results for the assay. The experiment was carried out in A549 cells, 
which show moderate difference in NF-kB activation between filaments and 
spheres. A549 cells were used as this assay was carried out before the 
RAW Blue cells became available. The A549 cells were grown in 6 well 
plates, and infected with one of the viruses at 3 MOI for 1 hour. The viruses 
were stained with anti-Udorn and anti-P65 antibodies. From the results it 
can be seen, that in all the spherical strains, NF-kB is activated, which is 




noticeably different in Udorn. However, NF-kB nuclear localization can also 
be seen in the filamentous A/Cal/09 strain, though the proportion of 
filaments to spheres produced by this A/Cal/09 strain is lower than that 
produced by A/Udon/72. Again, due to equipment failure, calculations could 
not be done. 
It was also important to show that Udorn suppresses NF-kB activation 
because of the filaments, and not due to any other effects of M1-A41V 
mutation. To test this, the Udorn virus was first vortexed. Vortexing Udorn 
causes the long filaments to break into spherical-like viruses (Rossman, 
2010), with no loss of infectivity. However, this does not affect the spherical 
viruses. Wild type Udorn and Vortexed Udorn was then used to infect 
MDCK cells for 1 hour at 3 MOI, and the results are shown in figure 3.19. 
The results show that the vortexed virus loses its ability to block NF-kB 
nuclear localization. This helps us to conclude that the reduction of nuclear 









Figure 3.18: NF-kB nuclear localization following infection of different 
strains of IAV in A549 cells. A549 cells were infected with the different virus 
strains at 3 MOI for 1 hour before immunostaining, fixation and mounting 
with DAPI (blue). The They were viewed with Epifluorescence Microscopy 
to look at NF-kB activity (green). The scale bar shows 10um. 






Figure 3.19 NF-kB nuclear localization in vortexed Udorn infected cells. 
Udorn was vortexed to break their filamentous structure, and the vortexed 
virus or M1-A41V was used to infect MDCK cells at 3 MOI for 1 hour before 
immunostaining, fixation and mounting with DAPI (blue). It was noticed 
again that with spherical viruses NF-kB is activated (green), which does not 









A/Udorn/72 is a mixture of filamentous and spherical virions. However, only 
15% of the virions are filamentous (Badham and Rossman, 2016), so even 
a small difference between A/Udorn/72 and M1-A41V represents a larger 
actual difference between filaments and spheres. Although filaments and 
spheres can be separated using ultracentrifugation as shown earlier, the 
filaments deform, and the purified filaments can thus not be used further for 
infection. As a result, we have to rely on these mixed morphology strains to 
test the hypothesis.  
From the above results it can be seen that filaments are somehow reducing 
NF-kB activation, compared to spherical virion infections. Although we are 
still not sure what causes the differential activation, some of the ways will 
be looked at the following sections, but there is enough evidence to show 
that filaments are somehow blocking the innate immune activation of the 
host cells. When infected with spherical virions, the IKKB pathway gets 
triggered and NF-kB gets activated and enters the nucleus of the cell, 
activating the inflammatory response. However, somehow filaments are 
stopping this activation from happening, and thus NF-kB is unable to enter 
the nucleus of the cells.  
The data also show that this phenomenon is not exclusive to Udorn and 
A41V, but all the other spherical strains also activate NF-kB. It was also 
shown that when Udorn filaments are fragmented into spherical-like 
viruses, they can no longer block NF-kB activation. This suggests that the 




virus is causing NF-kB activation due to some property of filamentous 
virions (i.e. filaments enter cells by macropinocytosis while spheres enter 





















3.3.2 Why is there a difference in NFkB activation with different 
virus morphologies? 
Although we saw a difference in NFkB activation between filamentous and 
spherical virions, we still do not know why there was a difference. So firstly, 
we looked to see if TLRs or their adapters have any role in IAV-dependent 
NF-kB nuclear localization. Toll like receptors are transmembrane proteins 
of cells of the innate immune system. They recognize foreign microbes and 
activate different signalling pathways, including NF-kB. So, do the 
filamentous and spherical virions differentially affect TLR activity, thus in 
turn, changing NF-kB activity? Next, it was determined if the viral entry 
pathway has any role in the NF-kB activation. Spheres enter mostly by 
clathrin mediated endocytosis which can be blocked with chloropromazine 
(CPZ), while filaments enter by macropinocytosis, which can be blocked by 
Na+/H+ pump inhibitor 5-(N-ethyl-N-isopropyl) amiloride (EIPA). The aspect 
that was investigates was  if any viral-induced changes in autophagy activity 
can in turn causes the changes in NF-kB activation. When virions enter cells 
by macropinocytosis, the autophagy pathway gets activated. NF-kB is one 
of the first responders of innate immunity, and both the effects of NF-kB 
and autophagy are very rapid. So, is it can be possible that the morphology-
dependent activation of NF-kB is driven by the autophagic pathway, and 
changes in autophagosome production due to morphological changes can 
cause the variation in NF-kB activation. 
 





3.3.2.1 Results: Are TLRs responsible for the changes in NFkB 
activity? 
Toll like receptors (TLRs) are a group of proteins which are important for 
activation of the innate immune system. TLRs can recognise structural 
proteins (PAMPs) of microbes and trigger the innate immunity pathways to 
defend the host against them. They activate intracellular signalling 
pathways that lead to changes in gene expression, and thus eventually stop 
the bacteria or virus from replicating and spreading further (Xagori and 
Chlichlia, 2008, Mahla, 2003).  
One of the pathways that gets activated when the TLRs respond to the 
PAMPs is the IKKB pathway to activate NF-kB. It was thus essential to look 
at if any TLR activations are affected by the change in morphology of IAV. 
Thus, macrophages from different TLR and TLR-adapter K/O mice were 
grown in the lab, and the NF-kB activity was assessed by imaging nuclear 
localization after infecting with A/Udorn/72 filaments or spheres. These 
modified macrophages each have a specific knock out (K/O), and these are 
shown in Figure 3.20.  





Figure 3.20 The toll like receptor pathway from O’Neill et al., 2013, modified 
to summarise the mouse macrophage K/O cells (in red) which were used 








 Figure 3.21 Confocal images of NF-kB nuclear localization in mouse 
macrophages, with specific K/Os, infected with either A/Udorn/72 or M1-
A41V at 3MOI for 1hour. The results show that with TRIF and TRAM K/Os 
there are no difference between NF-kB localization when infected with 
spheres or filaments. The green shows the immunostaining with p65 to 
show NF-kB activity. The scale bar shows 10um. 





  Student’s unpaired T test p-value (Udorn vs A41V) 
Wild Type TRIF TRAM TRIF/TRAM 
0.827498 0.81923482 0.422243 0.818757 
 
Figure 3.22 Graph showing the difference in NF-kB nuclear localization 
when infected with either Udorn or A41V. From the results it can be 
concluded that the TLR adapter proteins do not play any role in NF-kB 
activation due to morphological changes in the virus. The standard 



























Graph Showing NF-kB Nuclear localization in 








3.3.2.2 Results: role of specific TLRs in IAV NF-kB activation 
To test if any of the specific TLRs or their adaptor proteins play any role in 
NF-kB activation during infection with Udorn or A41V, mouse macrophages 
with specific K/Os were used. At first the macrophages that were used had 
K/Os of either TRIF or TRAM or a double K/O of TRIF and TRAM. The cell 
lines were infected with either Udorn or A41V, and then they were imaged 
with confocal, to look at NF-kB nuclear localization in the cells. This is 
shown if Figure 3.21. These were then used to calculate the ratio of NF-kB 
localization in the nucleus and cytoplasm of the cells, and the results are 
plotted in Figure 3.22. A student’s unpaired T Test (refer to ‘Appendix’ for 
calculations) was carried out, from the results it can be seen that there are 
no significant differences between Udorn and A41V infection. This means 
that the adaptor proteins TRIF and TRAM do not mediate the difference in 
NF-kB activation when infected with spheres or filaments.  
Next, specific TLR K/O mouse macrophages were used to check if they 
play any role in this NF-kB activation. The TLR K/Os used were TLR1, 
TLR2, TLR3, TLR4, TLR2/4 double K/O, TLR 6, TLR 7 and TLR 9. The cells 
were grown on 6 well plates and were infected with either Udorn or A41V  
at 3 MOI for 1 hour. They were fixed and stained with anti-Udorn, anti-P65 
(NF-kB) antibody and mounted with DAPI. The confocal images for the 
results are shown in Figure 3.23. The results for wild type mouse 
macrophages, without any TLR K/Os is also shown. The NF-kB nuclear 
localization of the different K/Os were then calculated, and the results are 
shown in Figure3.24. From the results it can be seen that when infected 




with Udorn, NF-kB activity rises in TLR 2, TLR3 and TLR2/4 K/Os. This 
suggests that either the filaments can somehow utilise TLR 2 and 3 to help 
reduce NF-kB activation or that these TLR K/Os alter other signalling 
pathways in the cell. It can also be noticed that with TLR 9 K/O, the NF-kB 
activity rises in A41V, this is unexpected as TLR K/O was expected to 
reduce NF-kB activation, so it can be suggested that spheres may exploit 
TLR 9 to somehow decrease NF-kB activation. However, it was also noticed 
that NF-kB activity is high in almost all the K/Os cells when compared to the 
wild type, suggesting there might be upregulation of other signalling 

















Figure 3.23 Confocal results to show the co-localization of NF-kB when 
infected with either Udorn or A41V, with different TLR K/Os. The different 
K/O mouse macrophages were infected with either M1-A41V or A/Udorn/72 
at 3 MOI for 1 hour. They were stained with α-Udorn (red), α-P65 (green) 
and DAPI (blue) and viewed with confocal microscopy. 
 
 






Student’s unpaired T Test p-values (Udorn vs A41V) 
TLR1 TLR2 TLR2/4 TLR3 TLR4 TLR6 TLR7 TLR9 Wild 
Type 
0.582 0.0046 0.0048 0.0291 0.2133 0.0987 0.6147 0.3428 0.32575 
 
Figure 3.24 Graph showing the confocal results from the NF-kB nuclear 
localization in different TLR K/O macrophages when infected with either 
Udorn or A41V and stained for P65. From this it can be seen that when 
there is a TLR 2, TLR 3 or TLR2/4 knockout, NF-kB activation when infected 
with filaments increases significantly. This means that filaments may uses 
these two TLRs to somehow block NF-kB activation. The Standard 
deviation is shown by the bars. The asterisk shows the p<0.05 when 









































It was suggested that the difference in NF-kB activity due to the change in 
morphology of IAV is due to the activity of TLRs or their adaptor proteins. 
This was looked into with specific K/O mouse macrophages. From the 
results it can be seen that the TLR adaptor proteins TRIF and TRAM do not 
have any effect on NF-kB activity. Specific K/Os of TLR were also looked 
into. It can be seen that TLR2 and TLR3 have a definite difference between 
NF-kB activation in M1-A41V and A-Udorn/72. This suggests that these two 
















3.3.3.1 Results: Does the specific IAV entry pathway play a role 
in NF-kB activation? 
As explained previously, spherical virus enters the host cells mainly via 
clathrin mediated endocytosis. Filaments are too large to use this pathway, 
and they thus instead use macropinocytosis to enter the host cells 
(Rossman, Lesser and Lamb, 2012). Spherical virions can also enter cells 
by macropinocytosis. 
From the previous section we concluded that filaments somehow can 
reduce NF-kB activation compared to spheres. However, we do not know 
how this happens. One of the possibilities is that the different IAV entry 
pathways might play a role in setting up this activation.  
To test this, RAW blue cells were grown in 6 well plates and they were 
treated with either CPZ, EIPA or both. Clathrin mediated endocytosis was 
blocked by using CPZ while macropinocytosis was blocked by EIPA. They 
were treated with one of the drugs or both for 1 hour. This was followed by 
infection with Udorn or M1-A41V at 3 MOI for 1 hour in the presence of the 
drug. The cells were prepared for immunofluorescence microscopy by 
staining for P65 (NF-kB) and were imaged by confocal microscopy. Figure 
3.25 shows the confocal results, with RAW cells treated with CPZ or EIPA 
or both, and infected with A41V or Udorn. The results do not show 
difference in NF-kB activation between Udorn and A41V, and when the 
entry pathways are blocked the results look similar. However, when both 
the pathways are blocked the NF-kB localization in the nucleus increases 




considerably, when infected with M1-A41V. The images were used to 
calculate the ratio of NF-kB in the nucleus and the cytoplasm of the cells 
(Figure 3.26). The results were used to do a Student’s unpaired T Test, 
which confirms that there is a significant difference between Udorn and M1-
A41V infection, when treated with both CPZ and EIPA. The control results 
also show a significant difference, with a p value 0f 0.007 between Udorn 
and A41V. Although the number of cells for the control was only 12, due to 
unforeseen reasons (instead of 30 like other conditions), but even then we 
can notice from the control that Udorn is significantly reducing NF-kB 
activation when compared to A41V infection. This is shown in more details 










Figure 3.25 To look at the effects of blocking entry pathways during IAV 
infection, either clathrin mediated endocytosis was blocked using 
Chloropromazene (CPZ) or macropinocytosis was blocked using 5-(N-
Ethyl-N-isopropyl) amiloride (EIPA). When these pathways are individually 
blocked, no significant difference is noticed in NF-kB activation due to 
infection by either Udorn or A41V. However, when both the pathways are 
blocked, suddenly NF-kB activation increases drastically, mainly when 
infected with A41V. The images show results from RAW Blue cells, infected 
with Udorn or M1-A41V at 3 MOI for 1 hour. They were stained with p65 to 
show the NF-kB activation (in green). The scale bar shows 10um. 





         Student’s T Test p-values (Udorn vs A41V) 
 
Figure 3.26 The nuclear and cytoplasmic intensities of NF-kB from the 
confocal image results were used to plot a graph. The Graph further 
confirms that, when CPZ blocks clathrin mediated endocytosis, and EIPA 
blocks macropinocytosis separately, there is no significant difference seen 
in NF-kB activation. However, when both the pathways are blocked, the 
difference changes considerably. NF-kB activity in A41V infection increases 
significantly, as seen by the Student’s unpaired T test, indicated by the 
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Udorn and A41V infection, as Udorn can more successfully reduce NF-kB 
activation during infection. The error bars show the standard deviation.   
This suggests that when IAV cannot enter cells by clathrin mediated 
endocytosis or macropinocytosis, the virus uses a third pathway to enter 
the cells, possibly in all cells or just in macrophages. To test if the third 
pathway is phagocytosis (one of the dominant immune stimulatory uptake 
pathways in macrophages), RAW Blue cells, grown in 6 well plates with 
media containing FBS or no FBS, were infected with fluorescently-labelled 
A41V virus (purple) at 3 MOI for 1 hour. During the infection, the cells were 
treated with fluorospheres (green), fluorescent-dextran (blue) and 
fluorescent-transferrin (red). Dextran is taken up by cells via 
macropinocytosis, while transferrin is taken up via clathrin mediated 
endocytosis. The fluorosphere beads enter cells by phagocytosis. The 4 
reagents were added directly to the cells and left for 2 hours. They were 
then fixed, and the slides were mounted and viewed by confocal 
microscopy. In Figure 3.27 it can be seen that in both conditions- cells 
grown in media with FBS, or cells grown in media without FBS, there was 
no co-localization between the virus and the fluorospheres, suggesting that 
IAV does not enter macrophages by phagocytosis, even in the presence of 
serum which enhances macropinocytosis. 












Figure 3.27 Activation of Phagocytosis after IAV infection. RAW Blue cells 
grown in media with (B) or without (A) FBS were infected at 3 MOI for 1 
hour with fluorescent M1-A41V (purple) and treated with fluorescent-
dextran (blue), fluorescent-transferrin (red) and fluorospheres (green) for 2 
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Although we know that NF-kB activation can be altered by viral morphology, 
we thought the entry pathways of IAV could have a role to play. However, 
we found that when blocking different entry pathways, the NF-kB activation 
does not change. Blocking clathrin mediated endocytosis by CPZ or 
macropinocytosis by EIPA does not have any effect on NF-kB activation, 
and the nuclear localization looks similar in both. However, when both the 
pathways are blocked, NF-kB activation suddenly increases, especially with 
spherical virus. This suggests that when both clathrin mediated endocytosis 
and macropinocytosis gets blocked, a third pathway gets activated that 
enhances NF-kB activation.  
It was assumed that the third pathway was phagocytosis, and this was 
looked into by treating RAW Blue cells with fluorospheres. However, the 
results showed that the virions did not enter by phagocytosis during 













3.3.4.1 Role of Autophagy During Early Infection of IAV 
 
Autophagy, which means “self-eating”, is a controlled process of removing 
unwanted cellular components from the body. It can aid in removal of 
proteins, maintaining homeostasis and assist in both innate and adaptive 
immunity. It happens in all nucleated cells (Ryter et al., 2013, Kroemer et 
al., 2010, Perot et al., 2018). 
Viruses can use autophagy to their advantage, to prevent inhibition by 
autophagosomes. RNA viruses can stop autophagosomes from maturing 
and replicate themselves inside the immature autophagosomes (Deretic 
and Levine, 2009). This helps them in staying undetected by the host’s 
innate immune system, and also increases their productivity by increasing 
their concentration (Perot et al., 2018). 
Influenza virus can also use autophagy during replication for their 
advantage, and it has been seen that when autophagy is blocked, IAV 
replication decreases (Zhou et al., 2009). When virions enter the cells by 
macropinocytosis, it can trigger autophagosomes to form, and thus activate 
autophagy. This can induce the innate immune system, by triggering the 
NF-kB pathway. Both the effects of autophagy and NF-kB occur rapidly 
after infection, so it can be suggested that autophagy may play a role in the 
changes in NF-kB activity due to changes in morphology.  
 
 




3.3.4.2 Results: Autophagy  
 
We know from previous data that IAV can efficiently utilize the process of 
autophagy for their advantage, to increase replication (Zhou et al., 2009, 
Perot et al., 2018). However, the question arises, if filamentous and 
spherical virions can cause any differences in autophagosome production 
during early infection that activates innate immunity, affecting NF-kB 
activity.  
To test this, MDCK cells were grown on 6 well plates and infected with either 
Udorn or M1-A41V virions at 3 MOI for 1 hour. The infected cells were 
prepared for immunofluorescence microscopy by staining with anti-Udorn 
and anti-LC3 antibodies and mounting with DAPI. The slides were viewed 
by epifluorescence microscopy. 
Figure 3.28 shows the epifluorescence microscopy results of LC3 
localization. In both the conditions, when infected with A41V or with Udorn, 
LC3 forms foci in the cells, indicating autophagy activation. However, 
similar number of foci seem to be produced, suggesting that morphology 
does not drive autophagosome activation. As this was not done with 
confocal microscopy, it could not be confirmed statistically. This means that 
the morphological changes of IAV do not appear to affect autophagy during 






















Figure 3.28 LC3 localisation in MDCK cells. Cells, grown in 6 well plates 
were infected with either A/Udorn/72 or M1-A41V at 3 MOI for 1 hour. They 
were stained with anti-LC3 (green), anti-Udorn (red) antibodies and DAPI 








As the epifluorescence data could not be quantified, we used the IncuCyte 
quantitative live cell imaging system to assess autophagy activation with 
the different morphologies. A549 cells stably expressing the autophagy 
reporter LC3-mCherry-eGFP were infected with A/Udorn/72 (at 1 MOI) or 
A/PR/8/34 (at 1 and 5 MOI) and imaged every 1 min for 120 min on the 
IncuCyte Zoom system. The mCherry of the autophagy sensor shows the 
total level of autophagy induction and the eGFP shows autophagy 
maturation, as GFP signal goes down when autophagosomes mature and 
are acidified but the mCherry signal remains the same. The first graph 
shows the total number of autophagosomes formed. It indicates that for all 
the 3 virus conditions, the number remains similar, indicating that 
morphology does not affect autophagy induction. The second graph shows 
the number of autophagosomes that mature. The levels start low, indicating 
mature autophagosomes, but with time the GFP intensity increases, 
meaning that they stop maturing. This is irrespective of virus morphology 
(spheres or filaments), confirming that during early infection 














Figure 3.29 IncuCyte data for autophagy formation and maturation. A549 
cells stably expressing LC3-mCherry-eGFP were infected with A/Udorn/72 
or A/PR/8/34 at 1 and 5 MOI and images were collected at 10x every 1 min. 




In both the graphs, Udorn is shown in red, PR8 1 MOI in grey and PR8 5 
MOI in yellow. The mock infected sample is shown in blue. Graph A shows 
mCherry fluorescence and indicates the total number of autophagosomes 
being produced, and it remains constant for all three conditions throughout. 
Graph B shows eGFP fluorescence and indicates the number of 
autophagosomes that mature. Lower levels indicate that autophagosomes 
are more mature. At first a drop is seen in the curve suggesting that 
autophagosomes form, but then the curve rises, indicating that they fail to 
mature during longer time durations. 
 
The ability of the virus to inhibit autophagy maturation was also confirmed 
by infecting A549 autophagy sensor cells with 3 MOI of filamentous 
A/Udorn/72, filamentous A/Cal/09 or the spherical mutant of Udorn M2-
Helix for 18 hours followed by staining with anti-M2 and imaging by confocal 
microscopy. The cells show green and red autophagy foci when infected 





















Figure 3.30 Autophagy mutation with diffident virus strains. A549 cells 
stably expressing LC3-mCherry-eGFP were infected with A/Udorn/72, 
A/Eng/09 or Udorn M2-Helix at 3MOI for 18hr before staining with anti-M2 
(blue) and viewing by confocal microscopy. Red foci indicate 
autophagosomes and green foci indicate immature autophagosomes. All 
strains activate the autophagy pathway and inhibit its maturation, 
regardless of virus morphology. 
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Autophagy is activated due to stress responses caused by IAV entering 
cells. Entry by macropinocytosis causes induction of the autophagic 
pathway. It was assumed that the activation of the autophagic pathway can 
induce NF-kB activation, as it is one of the first responders of the innate 
immune system, and both the pathways start working rapidly after infection.  
The activity of LC3 was looked into when A/Udorn/72 or M1-A41V infects 
hosts cells. It was hypothesised that the filamentous virions will somehow 
block the autophagic pathway. However, it was seen that both the 
morphologies work in the same way, activating autophagy during early 
stages of infection. During early stages of infection both spheres and 
filaments forms similar numbers of autophagosomes. Due to enhanced 
expression of the M2 protein at later stages of infection, IAV can withhold 
the autophagosomes from maturing. However, since the response remains 
similar in early stages, it can be said that early IAV NF-kB activation is not 












   
 
  CHAPTER 4 










4.1 Purification of A/Udorn/72 
IAV is a pleomorphic virus and consists of both filamentous and spherical 
virions. Some strains can only form spherical virions, while other strains can 
form a mixture of both filaments and spheres. When IAV is passaged in the 
lab, they are found to be spherical. However, filaments are continuously 
found in clinical samples, suggesting they are required to form for IAV to 
survive (Siezkarski and Whittaker, 2005).  
A/Udorn/72 is of pleomorphic nature and can form both filamentous and 
spherical virions. After continuous passaging, Udorn seems to retain its 
ability to form filaments, unlike other filamentous strains. A single mutation 
of Udorn at position 41 of M1 protein, causes the virus to stop forming 
filaments, and only forms spherical virions. For our experiments A/Udorn/72 
and its mutant M1-A41V were used. However, to confirm that they were 
indeed a mixture of spheres and filaments, the virions were purified by 
ultracentrifugation.  
The purification process successfully separated the spherical virions from 
the filamentous, confirming that the strain is indeed pleomorphic (figure 3.2 
and 3.3. However, the long and thin filamentous virions lose their shape 
because of the harsh ultracentrifugation process. This means that the 
virions cannot infect host cells as filaments anymore. If they would still 
remain infective and filamentous, then this could have been used to study 
the differences between filaments and spheres. Since, a pure filamentous 
strain does not exist, and the purification process is not amenable to 




subsequent infections, A/Udorn/72 and its mutant M1-A41V was the best 
strain to use for further experiments. 
 
4.2 Priming of host cells by UV treated Virus  
It has been suggested that some filamentous virions do not infect host cells 
at all, but are there to aid the infection of other spherical and filamentous 
virions (Badham and Rossman, 2016). These filamentous viruses may lack 
the ability to infect host cells or never be released from cells during budding. 
As filaments are long, they can come in contact with multiple host cells at 
the same time. This can induce macropinocytosis, thus other infective 
viruses may be able to enter the cells along with it. This priming mechanism 
could help the infective virions to be more successful and spread faster. 
To test this hypothesis, A/Udorn/72 and M1-A41V virions were inactivated 
with UV treatment. The UV treated virus was first introduced to the cells, to 
prime them, followed by infection with untreated virus. The results showed 
that there was no difference in the infectivity due to changes in morphology, 
i.e. both the spherical and filamentous virions showed similar levels of 
infection. However, it was noticed that priming of host cells beforehand did 
not aid infection. It actually reduced the level of infection. 
This suggests that priming of cells for infection with un-infectious virus does 
not aid in consecutive infection. The infection slows down, and the infectivity 
is reduced. This means that instead of aiding infection, it is actually reducing 
its efficiency. This may be due to the fact that once the cells are primed, the 




host’s immune system is already prepared for the infection, and it activates 
the host’s immune pathways to react to the infection immediately. Even 
during the first hour of infection the host’s innate immune system can 
produce NF-kB and IRF-7, which induces the production of proinflammatory 
cytokines and type I IFNs which can aid in reduction of infection (Iwasaki 
and Pillai, 2014). Alternatively, the duration of micropinocytosis induction 
could be very brief and end before the other virions reach the primed cell.   
 
4.3 Differences in NF-kB activation due to IAV morphology 
NF-kB is one of the first responders of the host’s immune cell, and the 
effects are rapid. To overcome this, IAV has schemed to manipulate the 
IKKB pathway, to use it to its own advantage (Nimmeriahn et al., 2004). 
Thus, it was worth looking at if viral morphology affects the early ability of 
the virus to activate NF-κB.  
To test this, A/Udorn/72 and M1-A41V were used to infect host cells and 
the activity of NF-kB was assessed. The results suggest that, during early 
infection, when infected with spherical virions the NF-kB pathway gets 
activated, as NF-kB enters the nucleus. However, when infected with 
filaments, this effect is much reduced. NF-kB localization in the nucleus is 
decreased, showing that it fails to get activated. This means somehow the 
filamentous virions are reducing the activation of NF-kB. This suggests that 
the filamentous virions have found a way to work around the NF-kB 
pathway, which may make them more effective when infecting hosts, during 




early stages of infection. However, we are not sure why and how this 
change in NF-kB activation occurs. 
 
 
4.4 TLRs can drive the changes of NF-kB activation 
TLRs are essential for many aspects of the innate immune system to work, 
as they recognise PAMPs from microbes, which triggers the innate immune 
pathways to respond to them. One of the pathways that gets activated is 
the NF-kB pathway. To test if TLRs or any of its associated proteins can 
cause the change in NF-kB activity, macrophages from specific K/O mice 
were obtained. 
The results showed that the associated proteins (TRIF and TRAM) did not 
have any effect on NF-kB activity when infected with spheres and filaments. 
They both produced the same level of activated NF-kB. Again, this was 
repeated on specific TLR K/Os and this showed that TLR2, TLR3 and 
TLR2/4 K/Os showed a significant difference in NF-kB activation, when 
infected with filaments versus spheres. This suggests that these TLRs can 
be responsible for the difference in NF-kB activation in filaments and 
spheres.  
It was also noticed that in almost all the TLR K/Os, the level of NF-kB activity 
was higher than in the wild type. This suggests, some other pathways may 




be upregulated due to the inhibition of the TLR and that this change in 
cellular signalling may have affected the TLR K/O results above. 
4.5 Entry Pathways do not play a role in NF-kB activation 
Spherical virions enter cells by clathrin mediated endocytosis, while 
filaments enter by macropinocytosis (Badham and Rossman, 2016). As the 
different morphologies enter by different pathways, this might have an effect 
on the NF-kB activity. When IAV enters the cells by macropinocytosis, the 
innate immune system gets activated, triggering the activation of NF-kB. 
Thus, it was assumed that the difference in entry pathway might bring about 
the change in NF-kB activation. 
To test this hypothesis, the entry pathways were blocked to see if it has any 
effect on NF-kB activation. Clathrin mediated endocytosis was blocked with 
CPZ and macropinocytosis was blocked by EIPA. When the pathways are 
blocked it was noticed that there is no difference in NF-kB activity when 
infected with Udorn or A41V. However, when both the pathways are 
blocked, NF-kB activation increases significantly with the spherical virions. 
This suggests a third pathway gets activated, when the normal pathways 
are blocked. It was thought that the third pathway might be phagocytosis, 
and this was looked into. The results show that the third pathway is not 
phagocytosis. However, this pathway might be another process of 
endocytosis and may result in stronger activation of NF-kB, when the usual 
pathways are blocked. It will be interesting to look at this further. This can 
be done by using a broader panel of chemical inhibitors to block additional 




variant endocytosis pathways and looking at NF-kB activation. It will also 
be worthwhile to look at if any other functional proteins are affected. Type I 
IFNs can be activated as a response to the production of IRF 7, during the 
early stages of influenza infection. Cytokines including interleukin-1B (IL-
1B) and IL-18 can also be released from phagosomes during the early 
stages of infection (Iwasaki and Pillai, 2014). These functional proteins can 
have an affect on the entry pathways of influenza, and it will be worthwhile 
to have a look at them.  
 
4.6 Autophagy in activating NF-kB pathway 
Autophagy is a controlled process of removing unwanted cellular 
components from the body. Autophagy can be induced by stress 
responses, which can be caused by microbes. When IAV enters cells by 
macropinocytosis, the cells can be triggered to produce autophagosomes. 
They can also be produced in response to TLRs recognising PAMPs. This 
can indirectly induce the activation of NF-kB activity. It was suggested that 
the production of autophagosomes can cause the change in NF-kB activity, 
and this can be controlled by the morphology of IAV. 
To test this, the activity of autophagosome production was looked into 
during early infection. From the result it can be seen that there was no 
difference in autophagy activation during early infection, due to changes in 
morphology. It was also shown due to infection, at later stages IAV infection 
can reduce the autophagosomes from maturing, but there is no difference 




between spheres and filamentous virions in this process. This means that 
autophagosomes are not driving the change in NF-kB activation due to 
morphological changes and morphology does not affect IAV-induced 
autophagy, during early stages of infection. However, if autophagy differs 
due to the difference in morphology at later stages was not looked into, and 
this may give different results, and will be worth looking into further. 
 
4.7 Conclusion and Future Work 
IAV is pleomorphic in nature and both the spherical and filamentous virions 
survive side by side. This suggests that they both play important roles in 
the survival and infection of virus. However, it is still unclear why the 
changes in morphology occur. We know that both viral and host factors play 
important roles in determining the morphology of the virus. Yet, it is still not 
known if that can cause a change in infectivity of the morphologies, nor 
what the function is of the different morphologies. 
Here, it was shown that priming of host cells does not affect infectivity of 
virus as was previously suggested. It was proposed that filamentous virions 
can prime the host cells beforehand, so that the spherical and filamentous 
virions can work effectively during infection. However, as shown in the 
results this is not true, and priming somehow slows the infection process. 
Only A/Udorn/72 and its mutant M1-A41V was used to show this. The 
experiments can be repeated with other filamentous and spherical strains 
to determine if this effect is applicable to all filamentous strains or is unique 




to Udorn and A41V. As epifluorescence microscopy was used to look at the 
results, they could not be as precisely quantified. So, it will be good to 
repeat the experiments with high resolution confocal microscopy and 
quantification. 
It was shown that filaments can decrease the activation of NF-kB, during 
early infection as compared to spherical virions. As NF-kB is one of the first 
responders of the innate immune system of the host, this is very important. 
It means that filaments can slow down the activation process of the innate 
immune system. Spherical virions cannot do this. It was also important to 
see why this change in NF-kB activation occurs.  
Firstly, it was important to see if this was driven by TLR activity. It was seen 
that TLR 2, TLR3 and TLR2/4 K/Os affect the difference in NF-kB activation, 
when infected with spheres or filaments. These TLRs also fail to activate 
the NF-kB pathway when infected by filamentous virions. It will be worth 
looking into how this happens and find the pathway by which filaments work 
and how NF-kB signalling differs in TLR K/O cells. For example, during a 
measles infection HA induces the activation of TLR 2 (Biebeck et al., 2002). 
This might also be occurring during influenza infection, and since the 
density and arrangement of the HA and NA differs in the different 
morphologies, this can cause the filamentous and spherical virions activate 
the TLR 2 differently. The glycoproteins on the surface of Ebola virus can 
help in activation of TLRs (Okumura et al., 2009), and it will be interesting 
to see if anything similar happens during influenza infection as well. MyD88 




is also an important TLR associated protein, and was not investigated in 
this study, but it should be looked into for future work. 
It was also suggested that since the two morphologies enter the host cell 
by different pathways, entry pathway might have an effect on NF-kB 
activation. Macropinocytosis can activate the NF-kB pathway. However, the 
results showed that there was no difference in NF-kB activity of the different 
morphologies due to the entry pathways. During the experiments it was 
found that when both the pathways of cell entry is blocked, IAV finds a third 
pathway to enter the cells. It was tested if the third pathway is phagocytosis, 
but the results show it is not. It will be good to find what the third pathway 
is, how it gets activated and if it works only in macrophages or in all cell 
types. It is possible that the third pathway is a variant of macropinocytosis 
or a different form of endocytosis, including caveolae endocytosis or CLIC/ 
GEEC pathway. Caveolae Endocytosis is an alternative clathrin 
independent endocytosis and is reported to be seen during influenza 
infection (Nunes-Correia et al., 2004).  
Autophagy can indirectly affect NF-kB activity via macropinocytosis, and 
this was also looked into. However, the results showed that 
autophagosome production remains similar between filaments and 
spheres, thus it does not affect the NF-kB activation difference. However, it 
was also shown that at later stages of infection, IAV can reduce 
autophagosome maturation. 




This study helped us to understand better how filamentous and spherical 
virions react differently to host and viral factors and how this may affect 
IAVs survival in nature. NF-kB is an important pathway which is one of the 
essential driving forces of innate immunity. If the path that filamentous virion 
take in blocking NF-kB activation can be found, it can be an important target 
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T Test results for difference in NF-kB ratio between nucleus and cell in 
















   
MDCK     
Udorn A41V   
0.436708 0.521316   
0.427391 0.50859   
0.42307 0.545773   
0.354085 0.530388   
  t test 0.001299478 
      
A549     
Udorn A41V   
0.352236 0.353413   
0.28248 0.327469   
0.331698 0.347606   
0.245844 0.32511   
  t test 0.208360619 








CPZ   EIPA   CPZ EIPA   
Udorn A41V Udorn A41V Udorn A41V 
0.32150176 0.37883873 0.479858 0.42457373 0.399281 0.914877 
0.41171814 0.39407483 0.486192 0.500463769 0.681186 1.174807 
0.46439245 0.5080407 0.409628 0.678625303 0.887329 1.101977 
0.42781517 0.42811727 0.444202 0.596977166 1.128102 0.996824 
0.42567396 0.60740546 0.390151 0.326089978 0.62764 0.864621 
0.65613591 0.47464409 0.322694 0.362998543 0.552074 0.857501 
0.40539661 0.48113627 0.389876 0.48820354 0.473577 0.859263 
0.48085766 0.42062738 0.409966 0.468976013 0.610933 0.83304 
0.48830768 0.52298296 0.481653 0.376902405 0.57449 1.204812 
0.28990635 0.46320435 0.420897 0.391032783 0.685986 1.198933 
0.43288173 0.41988981 0.414029 0.420200319 0.868347 1.482074 
0.36416226 0.42983329 0.452544 0.336344554 0.821067 0.980411 
ttest           
0.36637014     0.510447735   0.00034 
 
T Test results for measure of NFkB in cell nucleus vs entire cell for Wild 
Type Mouse Macrophages blocked with CPZ or EIPA, infected with 





















WT  TRIF  TRAM  TRIF TRAM  
A41V Udorn A41V Udorn A41V Udorn A41V Udorn  
0.42055 0.410553867 0.2019817 0.298438 0.255997 0.336122 0.361319 0.300001  
0.517186 0.369204527 0.38681223 0.308299 0.295457 0.336719 0.353017 0.300178  
0.320225 0.4323025 0.44198326 0.283926 0.297723 0.385079 0.341069 0.370171  
0.602008 0.41330711 0.30066581 0.368472 0.508291 0.316932 0.39047 0.355848  
0.4549 0.36393062 0.332889 0.247532 0.332073 0.37403 0.591698 0.375466  
0.352192 0.396891104 0.31935975 0.381593 0.345765 0.361675 0.532664 0.421323  
0.267941 0.424084825 0.33893891 0.334542 0.363995 0.395853 0.446278 0.481765  
0.288619 0.456007993 0.57928192 0.337551 0.411827 0.33611 0.3492 0.393859  
0.318769 0.346942138 0.50905398 0.667775 0.438549 0.300655 0.324956 0.3748  
0.581269 0.432141475 0.30554628 0.351101 0.306917 0.310902 0.307354 0.363755  
0.456618 0.346412601 0.43754388 0.494161 0.259277 0.283868 0.273139 0.331241  
0.469879 0.486591248 0.54572445 0.324373 0.443114 0.334168 0.457036 0.39806  
0.281543 0.34362382 0.2562814 0.459021 0.346065 0.271635 0.330207 0.315325  
0.515848 0.410216962 0.40468411 0.44439 0.326551 0.280932 0.305903 0.443253  
0.320582 0.445000588 0.43709509 0.360951 0.338291 0.317223 0.363377 0.359118  
0.454495 0.523051667 0.41739631 0.598333 0.327911 0.448311 0.407759 0.449228  
0.354756 0.381747732 0.32994517 0.404764 0.381529 0.268881 0.317554 0.275823  
0.641933 0.487241594 0.41216345 0.449418 0.296032 0.315294 0.347013 0.307869  
0.547674 0.389765444 0.28478757 0.312577 0.327158 0.318744 0.377594 0.399742  
0.427696 0.420490075 0.43363146 0.353355 0.515537 0.356059 0.263441 0.360838  
0.398577 0.374187836 0.5119439 0.281855 0.32617 0.293793 0.421171 0.468246  
0.311777 0.417994677 0.51308614 0.474352 0.280858 0.284489 0.377587 0.39143  
0.371099 0.480467999 0.28071288 0.304049 0.405314 0.408218 0.458299 0.404451  
0.439235 0.437372448 0.36748722 0.349337 0.316149 0.4624 0.39131 0.340891  
T Test         
0.827498   0.81923482   0.422243   0.818757    
 











TLR1   TLR2   TLR3   
Udorn A41V Udorn A41V Udorn A41V 
0.465274 0.519522 0.875172854 0.550919 0.529430593 0.593852 
0.457615 0.581871 0.882170418 0.60993 0.992680049 0.499885 
0.536257 0.645363 0.822319083 0.573706 0.90353167 0.764693 
0.606139 0.765312 0.829910349 0.566653 0.865557618 0.469122 
0.596266 0.516222 0.862674489 0.477661 0.781201248 0.553929 
0.562465 0.580976 0.860760264 0.402398 0.985067814 0.642715 
0.720938 0.559718 0.615223499 0.693806 0.563778828 0.541032 
0.436219 0.572908 0.73123988 0.762382 0.990039371 0.53664 
0.435382 0.545496 0.716807227 0.596752 0.914037922 0.421074 
0.672886 0.323341 0.707441834 0.857039 0.502321866 0.645939 
0.695572 0.38434 0.807352704 0.791526 0.585848138 0.59419 
0.641273 0.53648 0.792555813 0.821006 0.64156259 0.995136 
 T Test           
0.582486   0.004635414   0.029058506   
 
TLR4   TLR2/4   TLR6   
Udorn A41V Udorn A41V Udorn A41V 
0.86867058 0.578785 0.987952932 0.933667898 0.856247 1.394469525 
0.942383772 0.723412 0.904057371 0.730991827 1.619498 1.666750568 
1.095727046 0.656812 0.857149538 0.650057001 0.955566 1.250243819 
0.915284627 0.964679 1.124015566 0.965372516 0.992277 1.018490444 
0.816331994 0.511683 1.136425336 0.699952193 0.912994 0.909500629 
0.883017383 0.470193 0.973994608 0.75184129 0.889053 1.730194268 
1.107317659 0.514748 0.971435059 0.924792954 1.255344 0.996604303 
0.885718743 0.645755 1.120680788 0.718719231 0.669315 1.017497165 
0.749370958 1.446173 0.72593945 0.699952193 0.472422 1.072102529 
0.614826906 0.597072 0.78066393 0.75184129 0.370252 0.641591232 
0.756824757 1.093134 1.027118999 0.924792954 0.456637 0.89421272 
0.963306419 0.950293 0.805616508 0.718719231 1.144235 0.905174014 
 T Test           












TLR7   TLR9   WT   
Udorn A41V Udorn A41V Udorn A41V 
0.790055581 0.72965748 0.849619 0.73355749 0.371938 0.364833 
0.730113877 0.868324277 0.823988 1.010020467 0.53342 0.357966 
1.027969648 0.662961946 0.69363 0.904983189 0.438075 0.56348 
0.784693974 0.828915429 1.617419 1.442313693 0.374877 0.576796 
0.520724028 1.025704951 2.007786 1.481557632 0.40399 0.408367 
0.797300828 0.757795573 0.98248 1.01998781 0.497913 0.497864 
0.684405635 0.85359204 0.686814 1.139564316 0.477254 0.53601 
0.697858567 0.837141056 0.915628 1.242997799 0.586948 0.565265 
0.766840211 0.739281628 1.061226 1.53729251 0.523702 0.442533 
0.795146165 0.691396109 0.797038 1.458310254 0.452528 0.621478 
0.929578335 0.888348159 0.826061 1.273765118 0.54272 0.59076 
0.833515068 0.759413128 1.75309 1.525413868 0.4451 0.516508 
 T Test           
0.614651055   0.342804   0.325752   
 
T Test results for difference in NF-kB ratio between nucleus and cell in 
different TLR K/Os of mouse macrophages. 
 
 
        Average 
Udorn high 0.111 0.106 0.108 0.108333333 
Udorn low 0.145 0.147 0.139 0.143666667 
A41V High 0.096 0.097 0.093 0.095333333 
A41V low 0.782 0.852 0.805 0.813 
  T Test 
Udorn Vs A41V 
high 0.002320643 
   
Udorn Vs A41V 
low 5.49501E-06 
 
T Test results for Quanti blue Assay to look at difference of MOI of 
A/Udorn/72 Vs M1-A41V in activating NF-kB. 
 
 








Counting plaques from plaque assay for UV inactivated virus 
 
